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ABSTRACT 
 
Bioactive peptides are peptides that are able to exert beneficial health effects apart from 
providing the basic nutritional needs. In this study, bioactive peptides were produced and 
purified from alcalase hydrolysed salmon skin gelatin.  A gel filtration fraction, GF28, was 
identified as the most potent fraction. A further aim of this study was to investigate the 
bioactive properties including angiotensin converting enzyme (ACE) inhibition, 
antioxidant and anti-proliferative activities of the peptide. GF28 (5mg/mL) exhibited ACE 
inhibition activity of 46.5 %. Further studies elucidated that GF28 acts as a competitive 
inhibitor of ACE. GF28 also exhibited comparable peroxide formation inhibition activity 
to the positive control trolox (67.1 % and 67.3 % respectively). The antioxidant 
mechanism of GF28 mainly involved transition metal ion chelating activity and less 
reducing power activity. Apart from that, GF28 had poor radical scavenging activity in 
both hydrophobic and hydrophilic environments. GF28 also showed cytotoxic effects in 
hepatocellular carcinoma, HepG2 cells (IC50=0.154 mg/mL). In addition, GF28 also 
affected the endogenous antioxidant defence system in HepG2 cells by decreasing 
superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities as well as the 
amount of total glutathione. Catalase activity also significantly increased in 0.150 and 
0.175 mg/mL GF28-treated HepG2 cells (70.5 mU and 77.0 mU, respectively) compared 
to the control (47.9 mU). Anti-proliferative effects of GF28 were also observed in Caco-2 
cells (IC50=0.16 mg/mL).  In 0.15 mg/mL GF28-treated Caco-2 cells, intracellular and 
mitochondrial reactive oxygen species (ROS) (15.3 % and 7.8 % respectively) were 
significantly lower than untreated cells (32.9 % and 25.2 % respectively). Caco-2 cells 
treated with GF28 showed cell cycle arrest in the G1 phase as well as apoptosis. The 
extrinsic and intrinsic apoptosis pathways were activated with GF28. Caspase-8, caspase-
II 
 
3/7 and poly ADP ribose polymerase (PARP) were activated in the extrinsic pathway 
whereas caspase-9 and LaminA/C were activated in the intrinsic pathway.   
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1 GENERAL INTRODUCTION 
 
1.1 Amino acids 
 
 
Twenty naturally occurring amino acids are the essential building blocks of proteins. All 
amino acids have a common structure, depicted in Figure 1.1, which includes an α-carbon 
attached to an amino and a carboxylic acid group. The different chemical properties of 
amino acids are attributed to their unique side chains. Peptide bonds are covalent bonds 
formed between two amino acids where condensation will occur between the amino group 
of an amino acid with the carboxylic group of another amino acid. Two amino acids link to 
form a dipeptide and more amino acids are linked in the same manner, forming 
polypeptides that form proteins.  
 
Amino acids exist as zwitterions with the amino group in its conjugate acid form (NH3
+
) 
and the carboxyl group at a conjugate base form (-COO
 -
). Individual amino acids have 
their own characteristics due to their R-group (Fennema et al., 2008). In general, basic and 
acidic amino acids are hydrophilic due to their charged side chains which enable them to 
form hydrogen bonds with water molecules. Amino acids can be classified via their 
characteristic ability to react with water which are: (1) acidic, (2) basic, (3) non-polar, 
uncharged and (4) polar, uncharged respectively.   
Figure 1.1 Structure of an amino acid. 
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1.1.1 Acidic amino acids 
 
Both glutamic (Glu) and aspartic acid (Asp) belong to the acidic group of amino acids. The 
amino acids only differ in the number of methylene groups they possess where Glu has 
two methylene groups compared to one in Asp. Acidic amino acids are found to play a 
structural role in proteins where the carboxyl groups are able to form salt bridges within 
polypeptide chains in close proximity to one another. 
 
1.1.2 Basic amino acids 
 
Histidine (His), lysine (Lys) and arginine (Arg) are basic amino acids. In contrast to 
negatively charged acidic amino acids, basic amino acids are positively charged molecules. 
Basic amino acids can associate with acidic amino acids to form both salt bridges and ionic 
linkages. The opposing charges form salt bridges which are found in the centre of helical 
structures, which in turn stabilizes the tertiary structure and provides protein stabilization 
(Sundaralingam et al., 1985). 
 
1.1.3 Non-polar, uncharged amino acids 
 
Aliphatic and aromatic amino acids possess non-polar side chains that enable the amino 
acids to take part in hydrophobic interactions. The non-polar uncharged amino acids are 
normally found in the apolar face of α-helix and β-pleated sheets at the core of tertiary 
protein structures. Tryptophan (Trp) and phenylalanine (Phe) have benzene rings as side 
chains; thus, they are referred to as aromatic amino acids. The bulky aromatic rings also 
generally confer hydrophobicity (Golan et al., 2012). 
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Proline (Pro), isoleucine (Ile), leucine (Leu), valine (Val), alanine (Ala) and glycine (Gly) 
are aliphatic amino acids. Aliphatic amino acids possess hydrocarbon side chains with the 
exception of Pro where the side chain is covalently bonded to the amide backbone. As the 
aliphatic side chains increase in their bulk, the hydrophobicity increases due to the increase 
in the restriction of the hydrocarbon backbone flexibility (Huang and Nau, 2003). Gly has 
only one hydrogen atom as its side chain which enables more molecular flexibility than 
other aliphatic amino acids.Cysteine (Cys) and methionine (Met) have sulphur containing 
aliphatic side chains. Similar to the other aliphatic amino acids, they are uncharged and 
hydrophobic. 
 
1.1.4 Polar, uncharged amino acids 
 
Serine (Ser) and threonine (Thr) have hydroxyl aliphatic R-groups whilst tyrosine (Tyr) 
has a hydroxyl aromatic R-group. The –OH group enables the amino acids to participate in 
hydrogen bonding, thus their hydrophilic properties. In addition, the hydroxyl groups in 
Ser and Thr present as sites for carbohydrate attachment in the amino acids (Lodish et al., 
2000). 
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1.2 Protein structure and stability 
 
Protein structure can be categorised into four different levels which will be further 
discussed below (Fennema et al., 2008). The conformation and stability of proteins are 
governed by covalent and non-covalent bonds. Covalent bonds such as intra or interchain 
disulphide bonds are normally formed by the coupling of two thiol molecules and have a 
major influence on the stability of protein structures. In addition, peptide bonds, as 
described previously, are also covalent bonds.  
 
In contrast to covalent bonds, non-covalent bonds are less stable (Lodish et al., 2000). 
Hydrogen bonds are the sharing of the proton (H
+
) between two electronegative atoms. 
Electrostatic interactions can either be repulsive or attractive which can occur between any 
two charged particles. Van der Waals interactions are weak non-covalent bonds formed by 
the attractive interactions between dipoles. The packing of amino acid molecules in the 
interior of proteins illustrates the importance of van der Waals forces. Repulsive forces 
between non-polar molecules and water results in the interaction with other non-polar 
molecules. This preferred non-polar-non-polar molecule bond is referred to as hydrophobic 
forces.  Hydrophobic forces are the main interactions that dictate both the folding and 
stability of polypeptides or protein molecules in an aqueous environment. 
 
1.2.1 Primary structure 
 
The primary structure of protein is basically a linear chain of different amino acids linked 
by peptide bonds. In other words, the sequence of different individual amino acids along a 
peptide backbone constitutes the basic primary structure of protein. 
1.2.2 Secondary structure 
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Formation of hydrogen bonds locally within the polypeptide chain yields the secondary 
structure of protein. The most commonly observed secondary structures are α-helix and β-
pleated sheet (Fennema et al., 2008). 
 
In an α-helix, hydrogen bonds are formed between the oxygen atom in the carbonyl 
residue of an amino acid residue with the amide hydrogen residue of the fourth subsequent 
amino acid which creates a rigid and helical structure. Beta-pleated sheets are regular 
structures composed of β-strands linked by hydrogen bonds between the peptide 
backbones of adjacent strands. Beta-sheets are separated into parallel and anti-parallel 
conformations. Anti-parallel β-sheets are generally more stable than the parallel form as 
the co-linear hydrogen bond is the strongest form (Creighton, 1993). 
 
1.2.3 Tertiary structure 
 
Polypeptide chains assume their three-dimensional structure as they fold and twist into a 
range of complex, tangled shapes (Fennema et al., 2008). The folding into tertiary 
structures is achieved via the interaction between side chains of amino acids in the primary 
structure. These are mostly linked by non-covalent bonds with some covalent bonds which 
are mentioned and described previously. Tertiary structure of proteins can be divided to 
either globular or fibrous proteins. 
 
Globular proteins are densely packed structures of polypeptides. In general, hydrophilic 
amino acids are found on the surface whilst hydrophobic amino acids form the globular 
protein core. On the other hand, fibrous proteins are polypeptides arranged and packed as a 
single regular structure. Collagen is a fibrous protein with a repeating sequence of Gly-X-
Y. 
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1.2.4 Quaternary structure 
 
Multiple polypeptide chains (subunits) are linked via non covalent bonds to form a single 
large protein complex. In the interior of the complex, the interaction between the interface 
of subunits is similar to those amongst residues in globular proteins. Thus the role of 
hydrophobic interactions is critical in the stabilization of the quaternary structure. 
Although covalent bonds are found in low amounts, these strong linkages are vital to 
stabilize proteins with multiple subunits (Fennema et al., 2008). 
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1.3 Salmon 
 
The term “salmon” is derived from the Latin word Salmo, meaning “to leap”. Belonging to 
the family Salmonidae, salmon can be divided into two main genera Salmo and 
Onchorhyncus. Atlantic salmon are found in the North Atlantic whereas Pacific salmon are 
found in the North Pacific. The major difference between genera is that Pacific salmon die 
after spawning once, whilst Atlantic salmon can spawn multiple times, returning to the 
ocean in between.  
 
From raw to smoked salmon, salmon is enjoyed in different cuisines around the world in 
different ways. Consumption of salmon worldwide has increased significantly over the 
past decades; the total volume of world salmon supply increased from 550,000 metric 
tonnes (mt) in the 1980s to almost 2.5 million mt in 2004 (Knapp et al., 2007). A report by 
Marine Harvest (2010) showed that Atlantic salmon (Salmo salar) is the most widely 
farmed and sold species in the world.   
 
The drastic increase in salmon consumption is largely due to the highly desirable high 
omega-3 fatty acid content and lean protein content in salmon. It is well documented that 
both docosahexanoic acid (DHA) and eicosapentaenoic acid (EPA) promote health 
benefits such as improving childhood and adult brain development and performance, as 
well as reducing cognitive decline in the elderly (Kidd, 2007). Current investigations also 
show that both fatty acids are able to improve the lipid metabolism in obese non-diabetic 
patients (Itariu et al., 2012) and reduce inflammation (Calder, 2012) which is linked to 
diseases such as diabetes, arteriosclerosis and even hypertension. Apart from the health 
benefits, statements regarding the higher saturated fat and cholesterol content in other meat 
sources also makes salmon a preference. 
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1.4 Fish protein 
 
Fish is an attractive source of protein for an increasing number of health conscious 
individuals as it provides a very high quality protein with lower amounts of total fat and 
calories when compared to other meat protein sources. Although there are concerns about 
the mercury and polychlorinated biphenyl (PCB) levels, known immunotoxins (Lauriano 
et al., 2012) and carcinogens, fish remains one of the most popular protein sources 
worldwide. 
 
1.4.1 Myofibrillar protein 
 
Accounting for up to 65-80% of the total muscle protein, myofibrillar protein is the largest 
component (Gudmundsson and Hafsteinsson, 2002). Although the myofibrillar protein is 
made up of a further 20 types of proteins, myosin and actin (70% of the total protein) are 
the major component proteins. 
 
1.4.2 Sarcoplasmic protein 
 
Sarcoplasmic proteins are low molecular weight, water soluble, non-structural proteins. 
These proteins are found in the sarcoplasm bathing the myofibril proteins. Sarcoplasmic 
proteins can form protein films. Even when used in very low quantities (0.2%), 
sarcoplasmic proteins exposed to moderate pH (pH 5-9) have high emulsification 
properties (Yongsawatdigul and Hemung, 2010). 
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1.4.3 Non-soluble protein 
 
Non-soluble proteins of fish include all connective tissues which are insoluble in both 
water and low ionic solutions. Connective tissue plays a principle role in mechanical and 
structural support. However, mast cells and macrophages in connective tissues play a role 
in the immunological defence during inflammation. The low amount of connective tissue 
in fish (1.3%) makes the flesh more tender than the flesh of other animals. Collagen 
constitutes 90% of non-soluble fish proteins whereas the remainder is elastin 
(Gudmundsson and Hafsteinsson, 2002). 
 
1.4.3.1 Elastin 
 
Connective tissues with a high concentration of elastin are a yellowish colour. Elastin, a 
fibrous protein, is produced by most smooth muscle cells and fibroblasts which enable 
tissues and organs the ability to recoil when subject to pressure or stretching. Elastin is 
made up of randomly coiled polypeptides with irregular amino acid composition. The bond 
formed from the cross linking of the side chains of four lysine molecules is referred to as 
desmosine (Bhagavan, 2002). In the skin, elastin works with collagen to provide firmness 
and elasticity.  
 
1.4.3.2 Collagen 
 
Collagen is the major insoluble fibrous protein found in both connective tissues and the 
extracellular matrix such as skin and bone. It can also be found in small amounts in the 
intracellular matrix. In general, collagen is low in aromatic and sulphur amino acids such 
as Trp and Cys. Unlike elastin, it has a repeating motif of Gly-X-Y. Although X and Y 
residues can be any amino acids, mostly Pro and hydroxyproline (Hyp). Each amino acid 
 11 
 
plays a role in the triple helix where only the side chain of Gly, a H molecule, can fit into 
the centre to hold the helix by forming a peptide bond with the adjacent polypeptide.  
 
In general, Type I, III and V collagens are found in the skin of animals. However, Type III 
collagen is absent in fish skin. Apart from that, composition of Type I collagen differs in 
fish where one of the two α1 chains is replaced by an α3 chain. The α3 chain in Type I 
collagen is found in most bony fishes and is characteristic to skin collagen only. In 
Alaskan Pollock, swim bladder Type I collagen was the typical [(α1)2(α2)] heterotrimer 
whilst skin collagen [(α1)(α2)(α3)] (Kimura and Ohno, 1987). Phylogenetics also proved 
that the α3 chain is a product of divergence from the duplication of α1 gene (Saito et al., 
2001). Saito et al. (2001) also gave evidence that the lower stability of skin collagen is 
contributed by the loosened triple helical structure due to a higher amount of Gly-Gly 
doublets of the collagen molecule compared to α1. 
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1.5 Bioactive peptides 
 
Bioactive compounds are essential (e.g. proteins) and non-essential (e.g. polyphenols) 
components derived from food compounds that have an effect on human health (Biesalski 
et al., 2009). Inactive within the parent protein, bioactive peptides have to be released via 
enzymatic hydrolysis, food processing, microbial fermentation or gastrointestinal digestion 
(Bhat et al., 2015).  
 
Bioactive peptides are typically 2-20 amino acids long. Once liberated from the parent 
protein, bioactive peptides have functional properties apart from the nutritional properties 
(Korhonen and Pihlanto, 2003). Bioactive peptides can derive from a wide range of 
sources such as grains, plants, animals, dairy and marine sources. For example, wheat 
germ (Huang et al., 2014), hemp seed (Girgih et al., 2014), dry-cured ham (Gallego et al., 
2014), milk (Gobba et al., 2014), fish scale (Azuma et al., 2014) and red seaweed 
(Fitzgerald et al., 2014).  
 
1.5.1 Absorption 
 
The bioactivity of bioactive peptides is dependent on several factors including the 
absorption and bioavailability of the peptide itself. The peptide sequences of bioactive 
peptides have to be maintained during digestion so that they can act on the target cellular 
site (Shahidi and Li, 2015).  
 
Wada and Lönnerdal (2015) showed that bioactive peptides produced from human milk 
were resistant to in vitro digestion. Bioactive peptides can also be absorbed intact through 
the intestines intact (Gardner, 1988; Vermeirssen et al., 2002). However, the absorption 
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rate and kinetics of peptides are highly associated with physiological conditions such as 
the presence of carbohydrate or fibre in the gut (Ten Have et al., 2015). 
 
1.5.2 Production 
 
 Hydrolysis of precursor proteins with digestive enzymes, microbial fermentation and 
digestion with bacterial or fungal derived proteases are the common methods for 
producing biologically active peptides. If the desired peptide sequence is known, peptides 
can also be chemically synthesised.  
 
Many of the bioactive peptides are produced by the digestion of gastrointestinal enzymes 
such as pepsin, trypsin and chymotrypsin. Apart from that, bacterial or fungal derived 
enzymes such as alcalase and thermolysin are commonly used to produce bioactive 
peptides with functions such as anticancer (Kim et al., 2013), antioxidant and ACE 
inhibitory activities (Ambigaipalan et al., 2015). 
 
The use of highly proteolytic starter cultures in the production of fermented dairy products 
also leads to the production of bioactive peptides. Val-Pro-Pro and Ile-Pro-Pro are well-
known ACE inhibitory peptides which are produced from fermented milk products using 
Lactobacillus helveticus as a dairy starter (Sipola et al., 2001; Korhonen, 2009). Bioactive 
peptides were also produced in milk using yoghurt and cheese starters (Korhonen, 2009). 
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1.5.2 Factors influencing bioactivity of peptides 
 
Different methods can be used on various sources of parent proteins, which would produce 
many different bioactive peptides. The activities of these peptides are influenced by factors 
such as amino acid composition and sequence, peptide length, terminal amino acid, and 
electrical charge.  
 
1.5.2.1 Molecular weight (MW) 
 
Bioactive peptides are typically 2-20 amino acids long and less than 6 kDa (Sun et al., 
2004). Separation methods which are dependent on MW exclusion, such as ultrafiltration 
and gel filtration chromatography, are able to produce bioactive peptides with different 
MW ranges. However, small peptides were shown to have better anti-proliferative 
activities in cancer cells, antioxidant, ACE inhibition and antimicrobial activity when 
compared to larger MW peptides (Bhutia and Maiti, 2008; Khiari et al., 2014; Mosquera et 
al., 2014). 
 
1.5.2.2 Amino acid composition and sequence 
 
The different amino acids present in the bioactive peptides also play a major role in its 
activity. Aliphatic amino acids at the N-terminal, and aromatic amino acids at the C-
terminal were reported to act as the binding sites for ACE as competitive inhibitors (Byun 
and Kim, 2001).  The presence of proline in the penultimate position of peptides also 
contributes to ACE inhibition via the increase of enzyme binding (Contreras et al., 2009). 
Tryptophan and arginine rich peptides are also known for their antimicrobial and 
antifungal activities (Chan et al., 2006; Gopal et al., 2012). Hydrophobic amino acids also 
contribute to the antioxidant activity of bioactive peptides (Chi et al., 2015; Najafian and 
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Babji, 2015). This may be due to the fact that hydrophobic amino acids are more soluble in 
lipids.  
 
1.5.2.3 Electric charge 
 
Antimicrobial peptides tend to be cationic and amphiphatic. The cationic structure may 
interact with the outer bacterial membrane/ cell wall which is negatively charged (Teixeira 
et al., 2012). Conjugation of nanoparticles to a cationic peptide also improved anti-
inflammatory drug delivery to the corneal epithelium (Vasconcelos et al., 2015).  
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1.6 Functions of food derived bioactive peptides 
 
As discussed previously, food derived bioactive peptides may aid in the prevention or 
reduction of chronic diseases. For example, sea bream bone and scale derived bioactive 
peptides showed good ACE inhibition activity (Akagündüz et al., 2014). Multiple 
bioactive peptides derived from skate (Ngo et al., 2015), cuttlefish (Balti et al., 2015) and 
red seaweed (Fitzgerald et al., 2014) also exerted hypotensive effects in spontaneously 
hypertensive rats. These may play a role in reducing the risk of hypertension or 
cardiovascular diseases. Although more human studies are needed to confirm the activity 
of bioactive peptides in vivo, bioactive peptides may play an important role in the future as 
an alternative source of functional food or neutraceutical products. The potential uses of 
bioactive peptides on hypertension, in vitro and in vivo lipid oxidation as well as cancer 
will be further discussed below.  
 
1.6.1 Blood pressure and hypertension 
 
Blood pressure is the pressure exerted on the walls of blood vessels when blood is pumped 
throughout the body by the heart. Hypertension is a condition where systolic blood 
pressure ≥ 140 mmHG and/ or the diastolic pressure ≥ 90mmHG. According to the NHS, 
30% of the England’s population suffers from hypertension (NHS, 2014). Hypertension 
can also be linked to the increment of arteriosclerosis, stroke and renal failure (Kim and 
Iwao, 2000; Ishizaka et al., 2005).   
 
Blood pressure can be controlled by several mechanisms, divided into the long or short-
term control of blood pressure.  
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1.6.1.1 Short-term control: baroreceptors and chemoreceptors 
 
The autonomic nervous system affects blood pressure most rapidly. Baroreceptors located 
at the carotid sinus and aortic arch are mechanoreceptors which monitor both mean arterial 
pressure and pulse pressure in the arteries (Guyenet, 2006). The cardio-regulatory centre 
located at the medulla oblongata within the brain stem, acts as the integration centre for the 
afferent impulses from the baroreceptors. An increase in blood pressure will lead to the 
activation of the parasympathetic nervous system which leads to vasodilation and hence a 
decrease in blood pressure. 
 
Apart from baroreceptors, chemoreceptors are sensory neurons that are also located at the 
carotid sinus and aortic arch. They monitor the oxygen and carbon dioxide levels in the 
blood. The afferent signals from the chemoreceptors are conducted via the 
glossopharyngeal and vagus nerves separately to the cardioregulatory center (Dampney et 
al., 2001). A decrease in blood oxygen and increase in carbon dioxide results in the 
decrease of blood pH. This causes the activation of sympathetic nervous system which 
increases heart rate and stroke volume. The increased in sympathetic stimulation over 
blood vessels causes an increase in vasoconstriction which increases blood pressure. 
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1.6.1.2 Long-term control: renin-angiotensin-aldosterone system 
 
The kinin-nitric oxide system (KNOS), neutral endopeptidase system (NEPS) and the 
renin-angiotensin-aldosterone system (RAAS) are physiological systems responsible for 
the long term control of blood pressure. 
 
Kidneys help regulate blood pressure via the RAAS by affecting the blood volume. RAAS 
is regarded as the most important long-term control of blood pressure via vasoconstriction 
and vasodilation. The cascade process of RAAS is illustrated in Figure 1.2 below. Renin is 
an aspartyl protease released from the juxtaglomerular cells in the kidneys in response to 
stimuli such as renal arteriole hypotension, sympathetic nerve stimulation via β1-
adrenoceptors and decreased Na
+
 delivery to the renal tubule.  
 
Angiotensinogen is a glycoprotein mainly produced by hepatic cells with molecular weight 
varying from 55-60kDa depending on the extent of glycosylation (Abramowitz et al., 
2010). Angiotensinogen acts as the only substrate for renin where the peptide bond 
between Leu and Val would be cleaved splitting off the decapeptide angiotensin I (Ang I).  
Angiotensin-converting-enzyme (ACE) is a zinc-containing metalloprotease that cleaves 
the dipeptide His-Leu at the carboxyl terminal of Ang I which results in the formation of 
angiotensin II (Ang II). ACE is produced in the vascular endothelium of different tissues 
such as testis, brain and kidneys. Apart from Ang II production, ACE is able to degrade 
bradykinin, thus inhibiting vasodilation (Tschope et al., 2002). 
 
 AT1 and AT2 are the subtypes of receptor for Ang II where AT1 is expressed 
predominantly in adults whilst AT2 is expressed in the foetus (Ardaillou, 1999). The 
binding of Ang II to AT1 will lead to the release of aldosterone from the adrenal cortex, 
resulting in sodium and water retention as well as potassium excretion in the kidneys. The 
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octapeptide Ang II is also a potent vasoconstrictor which acts via the stimulation of 
vascular smooth muscle contraction and release of noradrenalin.  The cascade of events 
would lead to the elevation of blood pressure.  
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Figure 1.2 The renin-angiotensin-aldosterone system. 
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1.6.1.3 Treatment of hypertension 
 
Generally, lifestyle changes such as lowering salt consumption and eating a healthy, 
balanced diet are encouraged for hypertension patients. However, medication will be 
offered to patients with existing or high risk of cardiovascular disease and a consistent 
blood pressure above 140/90 mmHg or patients with a consistent 160/100 mmHg blood 
pressure (NHS, 2014).  
 
Different types of medications which act on different pathways and mechanisms of blood 
pressure control can be used in controlling hypertension. For example, ACE inhibitors, as 
suggested by the name, are used to inhibit the enzyme ACE and thus preventing the 
formation of the potent vasoconstrictor Ang II. Angiotensin receptor blockers target the 
AT1 receptors preventing the binding of Ang II to the receptors.  
 
However, blood pressure will be dependent on salt intake when the RAAS system is 
blocked (Burnier and Brunner, 2000). Thus, diuretics are often used together with ACE 
inhibitors. Different types of diuretics target different parts of the kidney nephron, 
reducing the reabsorption of sodium and water. Blood pressure is then reduced by the 
natiuretic effect which decreases extracellular volume.  
 
In addition, other drugs such as beta-blockers and calcium channel blockers are also used 
to treat hypertension. However, these synthetic drugs come with side effects such as 
headache, hypokalemia and dry cough as well as being teratogenic (Morimoto et al., 2004; 
Chu et al., 2014).  
 
On the other hand, recent studies showed that food derived bioactive peptides have no 
known side effects (Wijesekara and Kim, 2010; Sarmadi and Ismail, 2010). Balti et al. 
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(2015) identified bioactive peptides that are effective ACE inhibitors from cuttlefish 
muscle. Activity has been shown in spontaneously hypertensive ratsand the peptides 
although less potent than the synthetic drugs, do not possess any of the side effects of the 
synthetic drugs. Buttermilk is rich in milk fat globule membranes which have different 
unique bioactive peptides. Consumption of buttermilk was shown to reduce blood pressure 
in men and women and there were no associated side effects (Conway et al., 2014). 
 
More studies need to be undertaken to evaluate the safety and efficacy of bioactive 
peptides as an alternative means of hypertensive treatment. Apart from that, bioactive 
peptides can also be used with the synthetic drugs to minimize the dose used, thus 
reducing the side effects of the synthetic drugs.  
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1.6.2 Lipid oxidation 
 
Lipid peroxidation refers to the degradation of lipids. It is well known that oxidation of 
lipids, both in vitro and in vivo, has undesirable effects on both food and human health. 
Foods that are high in fat have a shorter shelf life compared to those with lower fat content 
as the oxidation of lipid can cause off flavours, colours and changes in texture, which 
affect consumer acceptance. Lipid oxidation also causes the loss of essential fatty acids 
and vitamins. Oxidised phospholipids can be found in hyperlipidaemic plasma and also 
atherosclerotic regions which are considered to be pro-atherogenic (Lee et al., 2012). The 
extent to which lipid is degraded is mainly dependent on the presence of sunlight, metal 
ions and the nature of the lipid itself. Double bonds make lipid molecules more prone to 
peroxidation. Thus, the higher degree of unsaturation of the lipid molecule makes it more 
susceptible to peroxidation.  
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1.6.2.1 Types of lipid peroxidation 
 
Lipid peroxidation can be classified into enzymatic, autoxidation and photoxidation types.  
 
Enzymatic oxidation: Enzymatic lipid oxidation involves an enzyme as a catalyst. For 
example, the enzyme lipoxygenase (LOX) is found in many oil-containing seeds such as 
soybeans. The Fe
2+ 
of LOX needs to be oxidised to Fe
3+
 before LOX can catalyse the 
oxygenation of polyunsaturated fatty acids to form hydroperoxides (Baysal and 
Demirdöven, 2006). Blanching inactivates LOX and may therefore prevent enzymatic 
peroxidation. 
 
Autoxidation: Autoxidation is the major process of lipid peroxidation. It is also 
spontaneous oxidation which involves unsaturated lipids and oxygen in the absence of 
light and catalyst (Sun et al., 2011). Free radicals are normally involved in the initiation of 
autoxidation where the lipid reacts non-enzymatically with the oxygen.  
 
Photoxidation: Photosensitization is the process where a light absorbing molecule 
initiates a reaction without changing itself. In photoxidation, ultraviolet light excites stable 
ground state oxygen excited to singlet oxygen (
1
O2) (Yousif and Haddad, 2013). 
Chlorophyll is an example of those molecules that absorb light and transfer the energy to 
oxygen. These compounds are referred to as photosensitizers.  
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1.6.2.2 Lipid oxidation mechanism 
The mechanism of lipid peroxidation involves: initiation, propagation and termination.   
 
Initiation: In general, the initiation of lipid peroxidation, the H
.
 of the α-methylene group 
in the double bond is removed to form a lipid radical (LO
.
) as well as a hydrogen radical 
(H
.
). The LO
.
 then reacts with oxygen to form an active alkyl radical (LOO
.
).   
 
Propogation: The LOO
.
 formed will then propagate lipid peroxidation via the further 
abduction of  H
+
 from other PUFA in proximity. The reduction of LOO
.
 causes the 
formation of peroxides (LOOH) which are odourless and colourless. LOOH is the major 
initial lipid peroxidation product which is an unstable compound and would breakdown 
over time. LOOH often decompose via dismutation which could either form more free 
radicals that further propagate the lipid peroxidation or volatile components such as 
aldehydes and ketones that contribute to the off flavours and rancidity of lipids. Trace 
quantities of metal ions such as copper ions (Cu
2+
) also act as a catalyst in the breakdown 
of LOOH.  
 
Termination: Termination occurs when two free radicals combine to form a non-reactive 
stable product. This process is referred to as radical recombination and the number of 
variation of possible recombination is limitless. However, the term termination can only be 
used on the free radical that is stabilised but not the entire lipid peroxidation itself. This is 
because if stabilization is achieved by hydrogen abduction or rearrangement, lipid 
peroxidation is still continued and propagated.  
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1.6.2.3 Free radicals and reactive oxygen species (ROS) 
 
Free radicals are molecules with an unpaired electron but able to exist independently. As 
free radicals have an unpaired electron, they are relatively unstable and readily react with 
other molecules. Reactive oxygen species (ROS) are free radicals containing oxygen. 
Hydrogen peroxide, superoxide anion, hydroxyl radical are commonly found ROS.  
 
In food products, free radicals take part in lipid peroxidation which would cause off 
flavours and rancidity. Biologically, free radicals react with DNA, lipids and proteins 
which would lead to tissue damage (Young and Woodside, 2001). ROS are also involved 
in the initiation and progression of diabetes mellitus, atherosclerosis and 
neurodegenerative disease (Uttara et al., 2009; Kaneto et al., 2010). 
 
As the excess of lipid peroxidation and free radicals show undesirable effects in both food 
products as well as human health, it is vital to control lipid peroxidation.  
 
1.6.2.4 Antioxidants 
 
Antioxidants are compounds with the function of retarding or preventing lipid peroxidation. 
This is achieved either by preventing the initiation or quenching the free radical to prevent 
further propagation of lipid peroxidation.  
 
Antioxidants used in food products can be mainly divided into synthetic or natural 
antioxidants. The ideal antioxidants used as an additive in food must show no toxicity 
including any adverse physiological effect, not be absorbed by the body, be stable in 
treated food even after 1 year of storage, economical, efficient at low doses and must not 
affect the properties of the food by being odourless and colourless.  
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Both types of antioxidants have to go through stringent tests by the Joint FAO/WHO 
Expert Committee on Food Additives (JECFA) and the European Community’s Scientific 
Committee for Food (SCF) to be approved as “generally regarded as safe” (GRAS) to be 
used in the food industry.  Toxicology of the compound is also evaluated using the 
acceptable daily intake (ADI). 
 
Apart from antioxidants in food products, antioxidants such as superoxide dismutase and 
glutathione are also found in biological systems. They are also referred to as the biological 
antioxidant defence system. The antioxidant defence system prevents the excess of free 
radicals and ROS in the body. 
 
1.6.2.4.1 Synthetic antioxidants 
 
Butylated phenols and polyphenols mainly constitute the main components of synthetic 
antioxidants. Artificial antioxidants are generally cheaper and more easily obtained 
compared to natural antioxidants. The efficacy of synthetic antioxidants is mainly 
dependent on the oxidation-reduction potential. Resonance delocalization and 
susceptibility to auto oxidation are also important. The maximum amount of synthetic 
antioxidant allowed in food products is 0.02%. 
 
 Butylated hydroxytoluene (BHT) is a monohydroxyphenol compound and most 
commonly used as a multi-use antioxidant including preservation of petrochemicals and 
animal feed. BHT acts as a chain breaking antioxidant where it accepts or donates a proton 
to the free radical to form a stable end product that prevents initiation or further 
propagation of auto oxidation. 
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 However, strong evidence shows that BHT induces carcinogenic or mutagenic effects; 
0.2M BHT causes aneugenic effects via the increase in proliferation and aneuploidy after 
24 hours exposure to the macronuclei (Hatzi et al., 2011). Thus, BHT has an ADI of 
0.125mg/kg body weight and is only allowed as an antioxidant in restricted foods such as 
oil as it is very thermostable.  
 
Therefore, there has been an increased of demand for naturally sourced antioxidants over 
the years due to the potential or known adverse effects of synthetic antioxidants. 
 
1.6.2.4.2 Natural antioxidants 
 
Currently, there is intensive research on antioxidant compounds from naturally occurring 
sources. This is due to the increased concerns over the adverse toxicology reports on 
synthetic antioxidants and the consumers’ preference for “natural sources” of antioxidants. 
Natural antioxidants, with the exception of carotenes and tocopherols, are generally more 
polar compared to synthetic ones (Pokorný, 2007). This would decrease the solubility of 
natural antioxidants in the lipid phase which would affect their efficiency in retarding lipid 
oxidation.   
 
The antioxidant effects of bioactive peptides in vivo are well established. Bioactive 
peptides derived from tuna backbone protein showed dose-dependent scavenging effects of 
several free radicals including DPPH, superoxide and hydroxyl radicals (Je et al., 2007). 
Bioactive peptides derived from various sources also exhibited metal chelation effects of 
iron (Yan et al., 2015), zinc (Xie et al., 2015) and copper (Torres-Fuentes et al., 2014).  
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1.6.2.4.3 Biological antioxidant defense system  
 
Free radicals are produced naturally in the body via normal metabolic processes. However, 
external factors such as smoking and exposure to X-ray will also increase free radical 
levels in the body.  Although a high concentration of free radicals is harmful, low to 
moderate levels of free radicals are essential (Valko et al., 2007). Excess free radicals in 
the body are removed or neutralised by the biological antioxidant defense system. 
 
Superoxide dismutase: Superoxide dismutase (SOD) is the only eukaryotic enzyme 
capable of detoxifying superoxide (O2
.
) (Van Raamsdock and Hekimi, 2012). It catalyzes 
the dismutation of the highly reactive O2
.
 to the less reactive H2O2. H2O2 is further 
neutralised by either glutathione peroxidase (GPx) or catalase. The dismutation of O2
-
 to 
H2O2 is as follows: 
 
2 O2
.
 + 2 H
+   
  →      H2O2 + O2 
 
Three forms of SOD exist in humans: extracellular SOD, cytosolic Cu/Zn-SOD and 
mitochondrial Mn-SOD (Matés et al., 1999). Apart from that, differential Mn-SOD 
expression in cancer cells may be linked to the different stages and types of cancer, which 
may be use as a target in cancer therapy (Dhar and St. Clair, 2012).  
 
Glutathione system: The glutathione system includes glutathione peroxidase (GPx) and 
glutathione reductase (GR). GPx is a selenium containing enzyme found in plants and 
microorganisms as well as mammals. GPx catalyze the reduction of H2O2 or 
hydroperoxides using reduced glutathione (GSH) to alcohols, water and oxidised 
SOD 
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glutathione (GSSG). Seven GPx isoforms exists where GPx1, GPx2, GPx3 and GPx4 are 
the major isoforms (Margis et al., 2008).   
 
GR is responsible for the conversion of GSSG back to GSH. GR can be found in the 
cytosol as well as mitochondrial compartments of eukaryotic cells (Couto et al., 2013). A 
high level of GR is important to ensure that adequate GSH is available to prevent oxidative 
stress.  
 
The roles of GPx and GR in the antioxidant defense system are shown in the following 
reaction. 
 
2 GSH + H2O2   →    GSSG + 2 H2O 
2 GSH + ROOH   →   GSSG +H2O + ROH 
 
GSSG + NADPH + H
+
   →   2 GSH + NADP+ 
 
Catalase: Catalase catalyses the conversion of H2O2 to oxygen and water shown below. 
Although CAT is not essential for survival in some cell types under normal conditions, it is 
important during oxidative stress conditions (Matés et al., 1999). 
 
2 H2O2   →   2 H2O + O2 
 
  
GPx 
GPx 
GR 
CAT 
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1.6.3 Cancer 
 
Cancer is defined as the condition where cells in a certain part of the body divide and grow 
uncontrollably (NHS, 2014). The uncontrollable cell growth will lead to the formation of 
either benign tumors or malignant tumors. Benign tumors are localised; they remain at 
their original site and do not invade or spread to other sites in the body. On the other hand, 
malignant tumors invade surrounding tissues, as well as spread to other sites using the 
circulatory or lymphatic system. The spreading of cancer cells is referred to as metastasis.  
 
In 2012, 14.1 million new cancer cases were diagnosed worldwide and 311,000 cases were 
diagnosed in the UK in 2011 (Cancer Research UK, 2015). Breast, bowel, lung and 
prostate cancer accounts for more than half of all cancer cases. Breast cancer accounts for 
15 % of all cancer cases but 7 % of mortality whereas lung cancer accounts for 13 % of all 
cancer cases with the highest mortality rate of 22 % amongst all cancers (Cancer Research 
UK, 2015).  
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1.6.3.1 Cell cycle and control of cell division 
 
Cell division consists of four major processes consisting of cell growth, replication of 
DNA, chromosome replication and cell division. Growth 1 phase (G1 phase) is the gap 
between mitosis and initiation of DNA replication. Cells are metabolically active and 
continuously grow during the G1 phase. However, DNA replication does not occur during 
G1 phase. When conditions are unfavourable for cell division, the G1 phase can be 
delayed and cells enter a resting state known as the G0 phase (Cooper, 2000). 
 
The G1 phase is then followed by the S phase. DNA replication and centrosome 
duplication occur during the S phase. Growth 2 phase (G2 phase) then occurs where cell 
growth continues. This phase is followed by mitosis phase (M phase) where cell growth 
stops and the cell divides into two daughter cells. 
 
G1 and G2 phases are gap phases which allow sufficient time for the cell to grow before 
committing to the S phase or M phase. Checkpoints also exist at different phases as quality 
controls. G1/S DNA damage checkpoint ensures the quality of DNA prior to DNA 
replication in S phase. Cyclin dependent kinase (CDK) activity is inhibited when DNA 
damage is detected, prevents progression to S phase and thus leads to cell cycle arrest and 
DNA damage or cell death. 
 
The minichromosome maintenance complex (MCM complex) is vital to ensure that DNA 
replication occurs precisely once. The MCM complex are licensing factors which bind to 
replication origins during the G1 phase only. Once activated, the activated complex moves 
along the chromatin and acts as a replication helicase initiating DNA replication as well as 
making the replication origin in an unlicensed state (Nishitani and Lygerou, 2002). 
Restriction on licensing is only relieved after the completion of mitosis which then enables 
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another round of DNA replication. Apart from that, spindle checkpoint ensures chromatids 
are properly attached prior to progression from metaphase to anaphase during the M phase 
(Lara-Gonzalez et al., 2012).  
 
1.6.3.2 Gene mutations 
 
Gene mutations can be permanent alterations of genes which can trigger the uncontrollable 
cell division leading to cancer. These gene mutations can be caused by hereditary 
mutations (Shlien et al., 2015) or external factors such as tobacco smoke carcinogens 
(Pfeifer et al., 2002). Few classes of genes are identified as important factors in controlling 
cell division and growth as well as cancer development. 
 
DNA repair genes: DNA repair can be divided into two major types: (1) DNA damage 
caused by external factors such as UV light exposure and endogenous factors such as 
oxidative stress DNA damage; (2) DNA damage caused during DNA replication (Lahtz 
and Pfeifer, 2011). Base excision repair (BER) and nucleotide excision repair (NER) are 
amongst the DNA repair pathways involved in the first type of DNA damage whereas the 
latter type of DNA damage follows the mismatch repair (MMR) pathway.  
 
In general, BER repairs small regions whereas NER repairs large regions of the DNA. On 
the other hand, MMR corrects errors of DNA replications such as DNA mismatch. 
Polymorphisms in DNA repair genes such as OGG1 S326C, XRCC1 R194W involved in 
the DNA repair pathways above were suggested to be correlated to carcinogenesis (Goode 
et al., 2002).  
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Proto-oncogenes and oncogenes: Proto-oncogenes are genes capable of causing cancer 
when mutated. The mutated proto-oncogenes are referred to as oncogenes. Chromosomal 
rearrangements, mutations and gene amplifications are mechanisms involved in oncogene 
activation (Croce, 2008).  
 
Cyclin D1 (CCND1) is a vital regulator in the cell cycle progression from G1 phase to S 
phase (Alao, 2007). CCND1 is also proven to be an oncogene where the deregulation of 
CCND1 promotes mitogen-independent proliferation as well as affecting other oncogenic 
effects such as angiogenesis (Musgrove et al., 2011). CCND1 mutations or overexpression 
were detected in several cancers including endometrial cancer (Moreno-Bueno et al., 
2003), breast cancer (Yu et al., 2013) and bladder cancer (Seiler et al., 2014).  
 
Tumor suppressor genes: Oncogenes drive abnormal cell proliferation and growth 
whereas tumor suppressor genes have the opposite effect of inhibiting cell proliferation 
and survival. Therefore, the absence of negative regulatory proteins due to the inactivation 
of tumor suppressor genes can lead to tumor formation (Cooper, 2000).  
 
For example, p53 tumor suppressor gene is involved in apoptosis induced by DNA damage. 
p53 mutations are a common feature of cancer. Mutations in p53 are found at different 
stages of cancer development including tumor initiation, tumor development and 
metastasis (Rivlin et al., 2011). Mutated p53 also showed oncogenic functions that are 
totally independent of wild-type p53 and exerts a dominant-negative characteristic (Muller 
and Vousden, 2013). 
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1.6.3.3 Cell death mechanisms 
 
Different cell death pathways exist where apoptosis and necrosis are the most common. 
However, other novel cell death pathways investigated include autophagy and necroptosis. 
 
Apoptosis: Termed as “programmed cell death”, apoptosis is required during foetal 
development. Apoptosis is required to remove the interdigital web of the limbs to sculpture 
individual embryonic fingers and toes (Díaz-Mendoza et al., 2013).  
 
Apoptosis can be initiated by either the external pathway or internal pathway. The external 
pathway involves the activation of death receptors of the tumor necrosis factor (TNF) 
superfamily which causes the propagation of apoptotic signals via caspase-8 cleavage 
(Fulda and Debatin, 2006). In the internal pathway, caspases are activated via the 
permeabilization of the mitochondrial outer membrane by apoptogenic factors such as 
cytochrome c (Fulda and Debatin, 2006).  
 
Activation of apoptosis can be characterised by several morphological features: nuclear 
and cytoplasmic condensation, blebbing, formation of apoptotic bodies and maintenance of 
membrane integrity (Fink and Cookson, 2005). 
 
Necrosis: Necrosis was initially thought to be a form of unprogrammed cell death but 
recent studies suggested that its occurrence and process might be tightly regulated 
(Golstein and Kroemer, 2007). Typical morphological characteristics of necrosis are 
cytoplasm vacuolation, plasma membrane breakdown and inflammation around the 
necrotic site (Edinger and Thompson, 2004). However, necrotic cells do not undergo 
chromatin condensation and DNA fragmentation which are characteristics of apoptosis.  
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Necroptosis: Cells undergoing necroptosis are morphologically similar to necrotic cells 
but the process is a regulated active type of cell death (Green et al., 2011). Unlike 
apoptosis, necroptosis does not require caspase activation.  Activation of T-cell receptor 
(TCR), Toll-like receptor (TLR) and in particular TNF, induces necroptosis (Tait et al., 
2014). Caspase-8/FADD mediated apoptosis is able to inhibit necroptosis (Zhou and Yuan, 
2014). 
 
1.6.3.4 Anticancer agents 
 
Conventional anticancer agents are cytotoxic compounds; those with significant 
cytotoxicity on cancer/tumor cell lines and which also caused tumor regression in murine 
tumor xenografts or allografts were normally selected (Narang and Desai, 2009). However, 
recent advances in molecular biology as well as a more in-depth knowledge of cancer have 
enabled the development of target-based anticancer agents. These target-based anticancer 
agents are designed to inhibit and/or modify molecular markers vital in cancer growth, 
development and metastasis.  
 
Natural alternatives pose as an attractive proposition for anticancer agents. Bioactive 
compounds, as explained previously, are naturally derived compounds which are able to 
exert health effects. Studies show that bioactive compounds are able to exert anti-
proliferative effects in different types of cancer cells via autophagy, apoptosis, cell cycle 
arrest and interference of cellular signal transduction (Gan et al., 2015; Milutinović et al., 
2015). 
 
Bioactive peptides derived from marine sources such as tuna (Hung et al., 2014) and 
oyster (Umayaparvathi et al., 2014), elucidated anti-proliferative effects on cancer cells. 
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However, the exact mechanisms of the anti-proliferative effects of bioactive peptides have 
not been investigated in depth.  
 
1.7 Aim and objectives 
 
The main aim of this project is to purify and identify peptides with bioactive properties 
from salmon (Salmo salar) skin gelatin. The objectives below were considered necessary 
to achieve the aim:  
 
 To extract gelatin from salmon skin 
 To prepare protein hydrolysates using alcalase, pepsin and collagenase 
 To purify a bioactive peptide fraction with the highest antioxidant and ACE 
inhibition activity using ultrafiltration and gel filtration 
 To investigate the antioxidant mechanisms of the purified fraction 
 To investigate the ACE inhibition mechanisms of the purified fraction 
 To investigate the anti-proliferation effect of the purified fraction on human 
hepatocellular carcinoma 
 To investigate the effect of the purified fraction on the antioxidant enzymes of 
human hepatocellular carcinoma 
 To investigate the effect as well as the mechanisms of anti-proliferative activity of 
the purified fraction on human colorectal adenocarcinoma 
 To analyse the amino acid composition of the isolated fraction 
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2 EXTRACTION AND PURIFICTION OF ANTIHYPERTENSIVE 
BIOACTIVE PEPTIDES FROM SALMON SKIN GELATIN 
 
2.1 Introduction 
 
High blood pressure or hypertension is a condition of the persistent increase in blood 
pressure. Hypertension is diagnosed when both the systolic and diastolic blood pressure 
consistently exceeds 140 mmHg and 90 mmHg respectively. According to Public Health 
England, more than 1 in 4 adults had hypertension in 2014 (Public Health England, 2014). 
Although normally asymptomatic, hypertension can lead to significant impact on health. It 
accounts for 45 % of deaths from heart disease (WHO, 2011).  
 
Several mechanisms are involved in the regulation of blood pressure in the human body. 
These include the kinin-nitric oxide system (KNOS), neutral endopeptidase system 
(NEPS), the renin-chymase system (RCS) as well as the renin-angiotensin-aldosterone 
system (RAAS).  RAAS is considered as the major regulator of the long term control of 
arterial pressure (Carey et al., 2000). As RAAS maintains blood pressure via sodium 
absorption, overactivity of RAAS can lead to the increased vasoconstriction thus the 
occurrence of hypertension. Elevation of blood pressure is achieved when angiotensin-I is 
cleaved to angiotensin-II which is a potent vasoconstrictor. The main enzyme responsible 
for the production of angiotensin-II is angiotensin converting enzyme (ACE). ACE works 
by hydrolysing the N-terminal dipeptide His-Leu of angiotensin-I (decapeptide) to produce 
angiotensin-II (octapeptide) (Crowley et al., 2006).  
 
ACE is a dipeptidyl carboxypeptidase which mainly consists of α-helices. A zinc ion and 2 
chloride ions are also incorporated in ACE. Zinc ion plays an important role in the 
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catalytic activity of ACE (Cushman and Andotti, 1999) whereas chloride ions might 
interact with both the substrate and enzyme. The active site of ACE is divided into 2 
subdomains by a deep and narrow channel. A ‘lid’ from α-helices is located in the N-
terminal of the active site which restricts access to large polypeptides that only permits 
small peptides as substrates for the active site (Natesh et al., 2004).  
 
Angiotensin receptors are divided into angiotensin type 1 or 2 receptors (AT1 or AT2) 
which have different functions. AT1 is expressed ubiquitously in the cardiovascular system 
whereas AT2 is mostly found in the developing foetus but its expression in the 
cardiovascular system is very low (Lemarié and Schiffrin, 2010). Binding of angiontensin-
II to angiotensin type I receptor (AT1) would lead to a cascade of events which result in 
vascular smooth muscle contraction and the release of adrenaline. This induces artery 
constriction and the increase of heart rate. Angiotensin-II also stimulates the release of 
aldosterone from the adrenal cortex, which leads to the retention of sodium in the distal 
nephron. In the kidney, activation of AT1 would lead to vasoconstriction and 
antinatriuresis (Klingbeil et al., 2000). 
 
Apart from being responsible for the production of the potent vasoconstrictor angiotensin-
II, ACE degrades bradykinin which acts as a vasodilator (Dendorfer et al., 2001). Thus, 
many hypertensive drugs are designed to act as ACE inhibitors. Although synthetic ACE 
inhibitors exhibit potent hypotensive activity, they can lead to many adverse effects 
including dry cough, skin rash as well as headache (Chu et al., 2014).  
 
As mentioned above, ACE inhibitors currently used to treat hypertension have significant 
adverse effects on health. Recent studies have shown the production of food derived ACE 
inhibitors. These ACE inhibitor peptides were successfully produced from different 
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sources especially marine sources such as sea bream bones and scales (Akagündüz et al., 
2014), cuttlefish wastewater (Amado et al., 2014) and snakehead fish (Ghassem et al., 
2013). The antihypertensive activity of the peptides were also confirmed in in vivo where 
oral administration of the bioactive peptides successfully decreased blood pressure in 
spontaneously hypertensive rats (Jung et al., 2006; Wang et al., 2008). 
 
The aims of this study were to isolate and characterise peptides with ACE inhibition 
activity from salmon skin gelatin. Gelatin from salmon skin was hydrolysed with different 
enzymes to compare their ACE inhibition activity. The best hydrolysate was further 
purified and compared in terms of their ACE inhibition activity. The ACE inhibition 
mechanisms and amino acid composition of the isolated peptide were also investigated in 
this study.  
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2.2 Method 
 
2.2.1 Materials and reagents 
 
The following materials and reagents were purchased from the different suppliers: 
 
Materials 
 
Suppliers 
 
Salmon 
 
M&J Seafood (Aylesbury, UK) 
 
Sodium hydrogen carbonate (NaHCO3) 
 
 
 
 
 
 
 
 
 
 
Sigma Aldrich (Dorset, UK) 
 
Citric acid 
 
Whatman paper No. 4 
 
Alcalase, ≥2.4 U/g 
 
Collagenase, ≥125 CDU/mg solid 
 
Pepsin, ≥250 units/mg protein 
 
Hydrochloric acid (HCl), ACS reagent 
 
Sephadex G-25 
 
Boric acid 
 
Sodium chloride 
Angiotensin converting enzyme (ACE), 
≥2.0 units/mg protein 
 
Hippuryl-Histidyl-Leucine (HHL) 
 
Zinc chloride (ZnCl2) 
 
Triethylamine (TEA), HPLC grade 
 
Phenylisothiocyanate (PITC), HPLC grade 
 
Sodium hydroxide (NaOH) 
 
 
Fisher Scientific (Leicester, UK)  
Sulphuric acid 
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Materials 
 
Suppliers 
 
Acetonitrile (ACN), HPLC grade 
 
Fisher Scientific (Leicester, UK) 
 
Trifluroacetic acid (TFA), HPLC grade 
 
0.22 µm filter 
 
Millipore (Feltham, UK) 
 
Ultrafiltration membrane cartridges 
 
Vivaspin (Epsom, UK) 
 
 
2.2.2 Gelatin extraction from salmon skin gelatin 
 
Gelatin was extracted from salmon skin using the method of Badii and Howell (2006). 
Salmon skin was descaled, cleaned and cut into small pieces (3 cm x 3 cm). The skin was 
frozen at -80 ˚C and then freeze dried. Freeze dried salmon skin (200 g) was defatted using 
1000 mL NaHCO3 (0.125 %) with 200 g of ice. The mixture was stirred at 4 ˚C for 30 min 
and centrifuged at 4500 x g for 5 min. The supernatant was discarded and the procedure 
with NaHCO3 was repeated until no fat was visible in the supernatant. The defatted fish 
skin was treated with 1000 mL 0.2 % NaOH for 15 h at 4 ˚C. The NaOH solution was 
discarded and the skin was rinsed with water. Then, the fish skin was treated with 0.2 % 
sulphuric acid (1000 mL) at 4 ˚C. After 8 h, the skin was again removed and rinsed with 
water. Next, the skin was treated with 1000 mL 0.7 % citric acid for another 12 h at 4 ˚C, 
then rinsed thoroughly with water. Gelatin was extracted from the treated skin with Milli-
Q water in 45 ˚C for 12 h. The skin was discarded and solution was filtered using a 
Whatman paper No. 4 in a Büchner funnel. The solution was frozen at -80 ˚C and freeze 
dried to obtain the gelatin. 
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2.2.3 Measurement of angiotensin converting enzyme (ACE) inhibition activity  
 
The ACE inhibition activity of samples was determined using the method from Wu et al. 
(2002) with slight modifications. All samples and reagents in this experiment were 
dissolved in 0.1 M borate buffer with 0.3 M sodium chloride (pH 8.3). Hippuryl-His-Leu 
(HHL) (2mM) was used a substrate for ACE. Samples (5 mg/mL) or captopril (0.5 mg/mL) 
were added to 50 µL of HHL and incubated at 37 °C for 10 min. The reaction was then 
stopped by the addition of 100 µL 1 M hydrochloric acid. Buffer was used as the control 
instead of the sample. 
 
Samples were analyzed in the HPLC (Ultimate 3000, Dionex) and eluted using two solvent 
systems: (A) 0.05 % trifluroacetic acid (TFA) in water and (B) 0.05 % TFA in acetonitrile 
(ACN) at 1 mL/min. The gradient step for the elution used was 5- 60 % solvent A in 0-10 
min, followed by a constant 60 % for 2 min, then returned to 5 % in 1 min. This was 
followed by isocratic elution for 4 min. Hippuric acid (HA) was detected at 228 nm using a 
Gemini-NX C18 column (Phenomenex). Data was analysed using the Chromeleon 
Software. The ACE inhibition activity was calculated using the formulae: 
ACE inhibitory activity (%) = ( 
   
 
 ) x 100 % 
Where C = Area under the peak of control 
 S = Area under the peak of samples/ positive control (captopril) 
 
 
 
 
 
 
  
 45 
 
2.2.4 Preperation and purification of bioactive peptides with ACE inhibition activity 
 
2.2.4.1 Preparation of hydrolysates from salmon gelatin  
 
The gelatin obtained was hydrolysed with three different enzymes. Gelatin solutions (1:50 
w/v) were made from the gelatin prepared in 2.2.2. The hydrolysis conditions, with 
modifications, for alcalase as well as collagenase and pepsin were as described by See et al. 
(2011) and Ranathunga et al. (2006) respectively. The temperature and pH (1 M HCl or 1 
M NaOH) were adjusted according to the enzymes used. The optimum conditions for the 
different enzymes used for the hydrolysis are shownin the table below: 
 
Enzymes Optimum conditions 
pH Temperature (˚C) 
Pepsin 2.0 37.0 
Collagenase 7.5 37.0 
Alcalase 8.0 55.0 
 
 
Enzymes (1 %) were added to the gelatin solutions and were incubated for 8 h whilst 
maintaining their appropriate temperature and pH. After the completion of digestion, the 
mixture was put into boiling water for 15 min to inactivate the enzymes, thus terminating 
hydrolysis of the gelatin. The hydrolysed protein was centrifuged (5000 x g) and the 
supernatant collected, lyophilised and stored at - 80˚C. ACE inhibition activity of the 
hydrolysates was compared using the method in 2.2.3 the hydrolysate with the highest 
ACE inhibition activity was chosen for further studies. 
 
 
Table 2.1 Optimum pH and temperature used for pepsin, collagenase and alcalase to hydrolyse salmon skin 
gelatin. 
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2.2.4.2 Ultrafiltration of salmon skin hydrolysate  
 
Freeze dried alcalase hydrolysates of salmon skin were dissolved in Milli-Q water (1: 10 
w/v) and vortexed to homogenise the solution. The solution was sequentially fractionated 
into different fractions using cartridges with different molecular weight (MW) cut-offs of 5 
kDa and 2 kDa. After passage through the 5 kDa membrane cartridges, aliquots were 
collected and further fractionated with the 2 kDa membrane cartridges. Fractions collected 
were labelled according to their MW range: Ultrafiltration fraction >5 kDa (UF-1), 
ultrafiltration fraction 2-5 kDa (UF-2) and ultrafiltration fraction <2 kDa (UF-3). The 
fractions were lyophilised and stored at – 80 ˚C. The ACE inhibition activity amongst the 
ultrafiltration fractions were compared as in 2.2.3 and the best fraction was chosen for 
further purification via gel filtration. 
 
2.2.4.3 Gel filtration chromatography  
 
UF-3 was further purified by gel filtration chromatography using HPLC with a gel 
filtration column (2.5 cm x 90.0 cm). 250 mg samples were dissolved in 5 mL 50 mM 
sodium phosphate buffer (pH 7) and filtered through a 0.22 µm filter. The gel filtration 
column was packed with Sephadex G-25 gel and the samples were injected onto the 
column. Samples were then run with the 50 mM sodium phosphate buffer for 10 h at a 
constant flow rate of 1 mL/min. A total of 121 fractions were collected and sufficient 
samples were pooled from 12 runs. The absorbance at 228 nm was determined and only 
fractions with a value of > 1 were collected to determine their ACE inhibition activity 
(2.2.3). The fraction with the highest activity was chosen to determine its ACE inhibition 
mechanisms. 
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2.2.5 ACE inhibition mechanisms  
 
2.2.5.1 Enzyme kinetics 
 
Different concentrations of HHL substrate (0, 2, 3, 4 and 6 mM) and peptide (0, 2.5 and 
5.0 mg/mL) were used in this experiment. HA produced from the different combinations of 
the HHL and peptide concentrations at reaction times (0-30 min) were determined using 
the method in 2.2.3. A Michaelis-Menten graph was first plotted to determine the 
maximum velocity (Vmax) of the reaction and the concentration of substrate leading to half 
of maximum velocity (Km). The Lineweaver Burk plot was also plotted to determine the 
enzyme kinetics.  
 
2.2.5.2 Differential scanning calorimetry (DSC) of GF28 and zinc chloride (ZnCl2) 
 
Micro DSCVII (Setaram, France) was used to determine the thermodynamics of 5 mg/mL 
GF28, 5 mM ZnCl2 and GF28-ZnCl2.  The method was based on Badii and Howell (2002) 
where an equal amount of sample (750 mg) and reference (Milli-Q water) was heated from 
8-80 ˚C (rate of 0.5 ˚C/min) then cooled back to 8 ˚C. The temperature when the peptide is 
denatured halfway is referred as transition temperature (Tm). Tm was measured using the 
tip of the peak. The enthalpy change was also measured by integrating the area under the 
peaks using the software provided (SETSOFT 2000).  
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2.2.6 Amino acid analysis of GF28 
 
2.2.6.1 Sample preparation 
 
GF28 (25 mg) was dissolved in 5 mL 6 N HCl in dark screw-cap vials. The vials were 
purged with nitrogen and stored at 110 ˚C for 24 h to completely hydrolyse the peptide. 
 
2.2.6.2 Derivatisation of amino acids with phenylisothiocyanate (PITC) 
 
Derivatisation of the amino acids of GF28 was according to Badii and Howell (2001). 1 
mL of the sample solution from 2.2.6.1 was centrifuged and 20 µL was transferred to glass 
microtubes. Amino acid standard (20 µL) was also added to another glass microtube. The 
samples and standard were mixed with 20 µL drying reagent and vacuum dried for 15 min. 
Derivatisation reagent (10 µL) was added to the microtubes, sealed and left at room 
temperature for 20 min. The mixtures were further vortexed and vacuum dried. After 10 
min, 20 µL of methanol was added and completely dried under vacuum. The residue in the 
glass microtubes were reconstituted with eluent A (0.05 % TFA in water) and analysed in 
the HPLC. 
Drying reagent: Methanol: Water: Triethylamine (TEA) (2:2:1) 
Derivatising reagent: Methanol: Water: PITC: TEA (7:1:1:1) 
 
2.2.6.3 Amino acid analysis using HPLC 
 
The prepared and derivatised samples/ control were analysed using HPLC (Ultimate 3000). 
Amino acids were separated using a C18 reverse-phase column (Phenomenex). Mobile 
phases of the analysis were: Eluent A: 0.22 M sodium acetate buffer with 0.05 % TEA, pH 
6.2 and Eluent B: ACN: water (60:40). The gradient profile used was: 0-10 min (A: 100 %, 
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B: 0 %), 10-10.5 min (A: 54 %, B: 46 %), 10.5-12.5 min (A: 0 %, B: 100 %), 12.5-20.5 
min (A: 100 %, B: 0 %). Amino acids were detected at 254 nm using integrated software 
(Chromeleon). 
 
2.2.7 Statistical analysis 
 
All experiments were done in triplicate (unless stated otherwise) and in three different 
experiments. Results were analysed using GraphPad Prism version 6.0. One way analysis 
of variance (ANOVA) was used to compare the means of the data followed by the Tukey’s 
post-hoc test unless stated otherwise. The details of the statistical tests were provided in 
the figure legends. A statistical difference was observed when p ≤ 0.05. Data were 
presented as mean ± standard error of mean (SEM). 
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2.3 Results 
 
2.3.1 Purification of salmon skin gelatin peptides with ACE inhibition activity 
 
2.3.1.1 ACE inhibition activity of pepsin, collagenase and alcalase hydrolysates from 
salmon skin gelatin 
 
Gelatin extracted from salmon skin was hydrolysed with three different proteases: pepsin, 
collagenase and alcalase. Figure 2.1 shows the ACE inhibition activity of the hydrolysates 
compared to captopril. All three hydrolysates showed significantly lower ACE inhibition 
activity compared to captopril (68.1 %). Alcalase hydrolysed salmon skin gelatin exhibited 
highest ACE inhibition activity (59.0 %) followed by collagenase hydrolysate (53.7 %). 
Pepsin hydrolysate showed lowest ACE inhibition activity of 43.6 %. Thus, alcalase 
hydrolysed salmon skin gelatin was chosen for further purification by ultrafiltration.  
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Figure 2.1 ACE inhibition activity of 5 mg/mL salmon skin gelatin digested by pepsin, collagenase and 
alcalase. Captopril (0.5 mg/mL) was used as a positive control. Means were compared using ANOVA 
followed by the Tukey’s post hoc test. A significant difference (p ≤ 0.05) to the control was represented by c. 
Data were represented as mean ± SEM (n = 9). 
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2.3.1.2 ACE inhibition activity of ultrafiltration fractions from salmon skin alcalase 
hydrolysate 
 
The ACE inhibition activity of ultrafiltration fractions of alcalase hydrolysates compared 
to captopril were presented in Figure 2.2. An increase in ACE inhibition activity was 
shown with a decrease in molecular weight of the alcalase hydrolysate of salmon skin 
gelatin. The ACE inhibition activity of ultrafiltration hydrolysates of UF-1 and UF-2 were 
52.4 % and 59.5 % respectively. Both showed significantly lower ACE inhibition activity 
than captopril (71.1 %). Only UF-3 (71.1 %) had ACE inhibition activity that was similar 
to captopril. UF-3 was then chosen for further purification using gel filtration via HPLC.  
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Figure 2.2 ACE inhibition activity of ultrafiltration fractions of alcalase treated hydrolysate. Captopril (0.5 
mg/mL) was used as a positive control. Means were compared using ANOVA followed by the Tukey’s post 
hoc test. A significant difference (p ≤ 0.05) to the control was represented by c. Data were represented as 
mean ± SEM (n = 9). 
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2.3.1.3 ACE inhibition activity of gel filtration fractions  
 
Gel filtration fractions were derived using Sephadex G25, collected and read using a 
spectrophotometer at 218 nm. Only GF-23 to GF-32 showed an absorbance higher than 1.0 
which indicated a high amount of peptide. These were chosen to investigate their ACE 
inhibition activity and the results were shown in Figure 2.3.  Captopril exhibited ACE 
inhibition activity of 82.5 % but GF23 to GF32 showed significantly lower ACE inhibition 
activity than captopril. ACE inhibition activity increased from GF23 (16.3 %) to GF28 
(46.5 %), then subsequently decreased to 13.1 % in GF-32. GF28 exhibited significantly 
higher ACE inhibition activity than other fractions collected. Thus, GF28 was chosen as 
the sample used to investigate the ACE mechanisms. 
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Figure 2.3 ACE inhibition activity of gel filtration fractions of alcalase hydrolysate against 0.5 mg/mL 
captopril as positive control. Means were compared using ANOVA followed by the Tukey’s post hoc test. A 
significant difference (p ≤ 0.05) to the control was represented by c. Data were represented as mean ± SEM 
(n = 9). 
GF 
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2.3.2 ACE inhibition mechanisms of GF28 
 
2.3.2.1 Enzyme kinetics of ACE with GF28 
 
Lineweaver Burk plot using 1/initial velocity (1/V0) against 1/Substrate concentration 
(1/[Substrate]) were plotted in Figure 2.4. According to the enzyme kinetics in Table 2.2, 
the maximum velocity (Vmax) of the samples: control, 2.5 mg/mL GF28 and 5.0 mg/mL 
GF28 were similar (10.5 mM/min). On the other hand, the concentration of substrate 
leading to half of maximum velocity (Km) increased with the concentration of GF28 used. 
Km values for control, 2.5 mg/mL GF28 and 5.0 mg/mL GF28 were 4.92, 6.61 and 9.64 
mM respectively.  The characteristic of similar Vmax values but an increase in Km indicated 
competitive inhibition of GF28 towards ACE.  
 
 
 
 
Control 
(No inhibitor) 
GF28 
2.5 mg/mL 5.0 mg/mL 
Vmax (mM/min) 10.46 ± 0.16 10.48 ± 0.21 10.49 ± 0.08 
Km (mM) 4.92 ± 0.11 6.61 ± 0.12 9.64 ± 0.03 
 
 
 
-0 .4 -0 .2 0 .0 0 .2 0 .4 0 .6
0 .2
0 .4
0 .6
0 .8
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1
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Figure 2.4 Lineweaver Burk plot of 0, 2.5 and 5.0 mg/mL GF28. Substrate (HHL) concentrations used were 
2-6 mM. Data were represented as mean (n = 9). 
Table 2.2 Vmax and Km values of control (no inhibitor), 2.5 and 5.0 mg/mL of GF28. Data were represented 
as mean ± SEM (n = 9). 
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2.3.2.2 Thermodynamics of GF28 in the presence of Zn
2+ 
 
In Figure 2.5, zinc chloride alone showed a straight line up to 80°C in DSC where no 
changes in the structure occurred. Apart from that, thermodynamics of GF28 alone 
exhibited 4 peaks  with different Tm (a = 25.1°C, b = 35.3°C, c = 46.3°C, d = 50.0°C) with 
an increase of temperature (Table 2.3) Different peaks also exhibited different enthalpy 
changes indicating that 1.59 J/g was needed at Tm (a = 25.1 °C) to denature the peptide. At 
d (50.0°C), the enthalpy change was 0.19 J/g where GF28 was completely denatured after 
this reaction. The thermodynamics of GF28 with ZnCl2 exhibited a different slope 
compared to ZnCl2 and GF28 alone.  
 
 
 
 
Peak Transition temperature, Tm (˚C) Enthalphy change (J/g) 
 
a 25.07 ± 0.14 1.59 ± 0.02 
 
b 36.34 ± 0.26 0.26 ± 0.31 
 
c 46.34 ± 0.04 0.14 ± 0.15 
 
d 49.95 ± 0.28 0.19 ± 0.20 
 
 
Figure 2.5 Thermodynamics of 5 mM ZnCl2 and GF28 alone as well as GF28 and ZnCl2 up to 90 °C using 
differential scanning calorimetry. Peaks detected were represented as a, b, c and d respectively. Data were 
represented as mean (n = 9). 
Table 2.3 DSC results for the transition temperature and enthalpy change exhibited in the denaturation of 
GF28. Peaks were represented by a, b, c and d respectively. Data were represented as mean ± SEM (n = 9). 
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2.3.3 Amino acid analysis 
 
Amino acid analysis of GF28 was represented in Table 2.4. Most amino acid can be found 
in GF28 where glycine was the most abundant amino acid (42.2 %). This was followed by 
alanine (12.9 %) and other amino acids were found to be less than 10 % in GF28. Apart 
from that, the predominant group of amino acids in GF28 were hydrophobic amino acids 
(28.3 %) (expressed as the sum of Ala, Val, Met, Isoleu, Leu, Phe, Pro, Tyr). Only 9.4 % 
of GF28 consisted of aromatic amino acids. 
 
Amino acids 
 
% amino acid in GF28 
Aspartic acid 
 
1.3 ± 0.04 
Glutamic acid 
 
4.4 ± 0.01 
Hydroxyproline 
 
3.1 ± 0.01 
Serine 
 
2.5 ± 0.002 
Glycine 
 
42.2 ± 0.05 
Histidine 
 
2.1 ± 0.02 
Arginine 
 
2.1 ± 0.01 
Threonine 
 
8.9 ± 0.008 
Alanine 
 
12.9 ± 0.04 
Proline 
 
2.3 ± 0.11 
Tyrosine 
 
0.9 ± 0.03 
Valine 
 
2.0 ± 0.01 
Methionine 
 
2.6 ± 0.06 
Cysteine 
 
0.9 ± 0.07 
Isoleucine 
 
1.1 ± 0.01 
Leucine 
 
2.5 ± 0.02 
Phenylalanine 
 
1.7 ± 0.02 
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Tryptophan 
 
4.7 ± 0.01 
Lysine 
 
1.8 ± 0.09 
Aromatic amino acids 
 
9.4 ± 0.06 
Hydrophobic amino acids 
 
28.3 ± 0.07 
 
  
Table 2.4 Amino acid composition (%) of GF28. Aromatic amino acids are expressed as the sum of Phe, 
His, Trp and Tyr per 100 amino acid residues and hydrophobic amino acids are the sum of Ala, Val, Met, 
Isoleu, Leu, Phe, Pro and Tyr per 100 amino acid residues. Data were represented as mean ± SEM (n = 
9). 
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2.4 Discussion 
 
2.4.1 Gelatin extraction and purification of bioactive peptides with ACE inhibitory 
activity from salmon skin gelatin 
 
In the past, bioactive peptides exhibiting ACE inhibition activity were isolated from 
different sources such as milk or muscle protein (FitzGerald and Meisel, 2000; Ryan et al., 
2011). However, the high amount of fish filleting by-products generated such as skin is 
also a source of valuable protein and could be used to obtain bioactive peptides.  
 
In this study, ACE inhibitory peptides were successfully isolated from salmon skin gelatin 
and further digested with three different proteases: pepsin, collagenase and alcalase. The 
ACE inhibition activity of the hydrolysates was investigated using the HPLC method. The 
alcalase hydrolysate (59.0 %) exhibited the highest ACE inhibition amongst the 
hydrolysates. However, the ACE inhibition activity of alcalase hydrolysate was still 
significantly lower than captopril (68.1 %). The difference in ACE inhibition activity of 
the hydrolysates may be due to the different enzyme cleavage specificity. Collagenase has 
a strong affinity to cleave at the peptide bond between Gly and a hydrophobic amino acid 
(Seltzer et al., 1990) whereas pepsin prefers to cleave after bulky amino acids such as 
leucine and phenylalanine (Palashoff, 2008). Alcalase exists as a crude enzyme and 
contains several different proteases apart from its main component subtilin Carlsberg 
(Doucet et al., 2003). The different proteases in alcalase also have different peptide 
cleavage sites which could lead to a higher degree of hydrolysis compared to pepsin and 
collagenase. Thus, more bioactive peptides that possessed ACE inhibition activity can be 
obtained when digested with alcalase.  
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The alcalase hydrolysate of salmon skin gelatin was ultrafiltered and separated into 3 
different MW range. As shown in Figure 2.2, the ACE inhibition activity was found to be 
inversely proportional to the MW of the fractions. The ACE inhibition activity increases 
from 52.4 % in UF-1 (highest MW fraction) to 71.1 % in UF-3 (lowest MW fraction). 
Smaller MW peptides may be an advantage in the inhibition of ACE as only small peptides 
are accessible to the active site, thus the inhibition of ACE (Natesh et al., 2004). UF-3 was 
chosen to be further purified by gel filtration. 
 
Amongst the 121 fractions collected, only gel filtration fraction number (GF) 23 to GF32 
exhibited an absorption higher than 1.0 at 228 nm. So, the ACE inhibition activity of GF23 
to GF32 was investigated. Amongst the fractions, the ACE inhibition activity of GF28 was 
the highest (46.5 %) but significantly lower than captopril (82.5 %). However, a lower 
ACE inhibition activity of the gel filtration fraction was observed compared to 
ultrafiltration fraction (UF-3). Most studies (Zhuang et al., 2012; Zou et al., 2013) found 
an increasing ACE inhibition activity with purification but results found in this study were 
similar to the one observed in Campos et al. (2013). The ACE inhibition mechanisms of 
GF28 were investigated using enzyme kinetics and thermodynamics studies of the peptide.  
 
2.4.2 ACE inhibition mechanisms of GF28 
 
According to the enzyme kinetics, data provided in the Michaelis-Menten graph is 
summarised in Table 2.2. Vmax was found to be constant at 10.5 mM/min and a gradual 
increase in Km when the concentration of GF28 was increased. As an inhibitor, GF28 had 
no effect on the Vmax but increases Km suggests that GF28 acted as a competitive inhibitor 
of ACE (Berg et al., 2002).  The intercepts on the 1/v0 axis of the Line-Weaver Burk plot 
(Figure 2.4) also showed that GF28 is a competitive inhibitor which competes with the 
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substrate (HHL) at the active site of ACE. This inhibitory mechanism of GF28 is similar to 
the antihypertensive drug (captopril) used in this study (Chen et al., 2013). Most studies 
showed peptides from fish sources that exhibited ACE inhibition activity are mainly via 
mixed type (Mäkinen et al., 2012) or non-competitive inhibition (Qian et al., 2007; Wang 
et al., 2008; Lee et al., 2014). Only a few peptides from marine sources were shown to 
exhibit competitive inhibition of ACE such as from fermented oyster sauce (Je et al., 
2005). 
 
ACE is a metalloprotein exopeptidase. A zinc ion can be found in the active site of ACE 
which plays a role in the hydrolysis action of the enzyme. Thus, the inhibition of the zinc 
ions may lead to the inhibition of ACE activity (Cushman and Andotti, 1999). The ability 
of GF28 to bind to zinc ions was investigated using DSC. In Figure 2.5, increase in 
temperature did not show an effect on ZnCl2 and 4 peaks were detected in the 
thermodynamics of GF28 alone. The 4 peaks may indicate 4 different peptides with 
different degradation temperature shown in Table 2.3. The Tm of the last peak (d), 49.95 
˚C, suggested that GF28 was half degraded at this temperature. This characteristic of the 
four different peaks were missing in the thermodynamics of GF28 with ZnCl2 mixture. 
Apart from that, the graph was also different to the graph of ZnCl2 alone. This indicated 
that GF28 was able to bind to zinc ions in the active site of ACE which lead to the 
inhibition of ACE. 
 
2.4.3 Amino acid analysis 
 
Amino acid analysis results in Table 2.4 showed that GF28 is composed mainly of glycine 
(42.2 %) and the predominant group of amino acid is hydrophobic amino acid (28.3 %). 
Three subsites, S1 (antepenultimate), S1’ (penultimate) and S2’ (ultimate) are located in 
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the two active sites of ACE. Apart from that, the subsites have a preference for 
hydrophobic tri-peptide residues at the C terminal of the ACE inhibitory peptides (Pripp et 
al., 2005). There was also a preference for bulky aromatic amino acids such as Phe, His, 
Tyr and Trp at the S’ position, which may increase the binding of the peptides to ACE. 
Aromatic amino acids, which account for 9.4 %, in GF28 may block access of the 
substrate to the active site thus increasing the ACE inhibition activity of the peptide 
(Kobayashi et al., 2008).   
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2.5 Conclusion 
 
Gelatin was successfully extracted from salmon skin and hydrolysed using different 
proteases. Alcalase hydrolysate was found to possess the highest ACE inhibition activity 
compared to collagenase and pepsin. A higher degree of hydrolysis was achieved by using 
alcalase as mentioned in the discussion. Alcalase hydrolysate was further purified using 
ultrafiltration and gel filtration chromatography. The ACE inhibition activity of the gel 
filtration fraction (GF28: 46.5 %) was lower than the ultrafiltration fraction (UF-3: 71.1 %). 
This may be due to the exclusion of large aromatic amino acids responsible for the ACE 
inhibition activity during gel filtration. Thus, the amount of aromatic amino acids may be 
lower in GF28 than UF-3. 
 
The ACE inhibition mechanisms were elucidated using GF28. Enzyme kinetics showed 
competitive inhibition of ACE. Thermodynamics of GF28 in the presence of ZnCl2 also 
showed that GF28 was able to bind to Zn
2+
. This further confirmed the competitive 
inhibition of ACE as Zn
2+
 acts as an important factor in the active site of ACE. The 
presence of high amount of hydrophobic amino acids (28.3 %) as well as aromatic amino 
acids (9.4 %) in GF28 may also be responsible for the ACE inhibition activity of the 
peptide. Although these findings indicate the potential for producing peptides with anti-
hypertensive abilities, in vivo and clinical studies are needed before they can be used for 
neutraceutical applications and functional foods.  
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Chapter 3 
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3 EXTRACTION AND PURIFICATION OF BIOACTIVE PEPTIDES 
WITH ANTIOXIDANT ACTIVITY FROM SALMON SKIN GELATIN 
 
3.1 Introduction 
 
Lipid peroxidation is the oxidative degradation of lipids which can lead to many 
undesirable effects. In food products, lipid degradation causes undesirable effects in the 
colour, texture, flavour and smell of food which also affects the quality and shelf life. 
Evidence has shown that in vivo lipid peroxidation is associated with many diseases 
including neurological disorders (Shichiri, 2014), atherosclerosis (Chisolm and Steinberg, 
2000), type 2 diabetes (Santoro et al., 2014) and cancer (Thanan et al., 2015; Zhong and 
Yin, 2015). 
 
Unsaturated fatty acids, especially polyunsaturated fatty acids (PUFA), are more 
susceptible to lipid peroxidation than saturated fatty acids as lipid peroxidation increases 
with the amount of double bonds present in the lipid. Antioxidants play an important role 
in food products, where they help to maintain the sensory and nutritional quality of the 
food as well as the shelf life. Synthetic antioxidants are normally phenolic compounds 
which include 2-tert-butyl-4-hydroxyanisole (BHA) and 2,6-di-tert-butyl-hydroxytoluene 
(BHT). These synthetic phenolic antioxidants are cheap and very effective in protecting 
lipids against peroxidation (Sarin et al., 2010).  
 
The European Food Safety Authority concluded that there were no concerns in 
genotoxicity regarding the use of BHA. The long-term toxicity and carcinogenicity in the 
fore-stomach of rats were also not relevant to human risk assessment (EFSA Panel on 
Food Additives and Nutrient Sources added to Food, 2011). However, high doses of 
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phenolic synthetic antioxidants showed endocrine disruptive effects (Pop et al., 2013). 
Apart from that, there is a consumer led demand in the reduction of synthetic food 
additives including synthetic antioxidants as well as the preference for natural food 
additives. In different mixtures of synthetic antioxidants, the interaction between 
antioxidants at high temperatures could lead to a negative synergism (Allam and Mohamed, 
2002).  
 
Ascorbic acid and tocopherols are the most common natural antioxidants used in food 
products. Plant extracts exhibited potent antioxidant activity as the activity is strongly 
associated with the amount of phenolic compounds present (Velioglu et al., 1998). 
However, the use of plant extracts, particularly extracts from herbs and spices, should be 
carefully evaluated as they can influence the sensory acceptability of the food product 
(Yanishlieva et al., 2006). 
 
Bioactive peptides exhibiting antioxidant activities were successfully isolated from marine 
sources such as croceine croaker (Chi et al., 2015), cod (Girgih et al., 2015), squid 
(Nakchum and Kim, 2015) and half-fin anchovy (Song et al., 2015). Depending on the 
amino acid composition and sequence, the bioactive peptides isolated showed antioxidant 
activity via different antioxidant mechanisms. The main antioxidant mechanisms were 
metal ion chelation, reducing power activity and radical scavenging activity.  
 
In this study, gelatin was isolated from salmon skin and hydrolysed with different 
proteases acting at different cleavage sites. The hydrolysate exhibiting the highest peroxide 
formation inhibition activity was further purified via ultrafiltration and gel filtration 
chromatography. The fraction with the most potent antioxidant activity was determined 
using the ferric thiocyanate (FTC) method.  Then, the different antioxidant mechanisms of 
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the fraction was investigated using the reducing power assay, ABTS and DPPH 
scavenging activity assays as well as the copper and ferrous ion chelating activity assays. 
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3.2 Methods 
 
3.2.1 Materials and reagents 
 
The following materials and reagents were purchased from the different suppliers: 
 
Materials 
 
Supplier 
  
Ascorbate, ≥99.0 % 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sigma Aldrich (Dorset, UK) 
 
Trolox, 97 % 
 
Linoleic acid, ≥99.0 % 
 
Ferrous chloride (FeCl2), 98 % 
 
Ferric chloride (FeCl3), reagent grade 
 
Potassium ferricyanide 
 
Trichloroacetic acid (TCA), ACS reagent 
 
Ammonium thiocyanate, ACS reagent 
 
1,1-diphenyl-2-picrylhydrazyl (DPPH) 
2-tert-butyl-4-hydroxyanisole (BHA), 
≥98.5 % 
2,2’-azinobis-(3-ethylbenzothiazoline-6-
sulfonic acid) (ABTS), HPLC grade 
 
Potassium persulfate, ACS reagent 
 
Ferrozine 
 
Ethylenediaminetetraacetic acid (EDTA) 
Copper (II) sulphate pentahydrate, ACS 
reagent 
 
Pyrocatechol violet 
 
Sodium acetate, ACS reagent 
 
Absolute ethanol, HPLC grade 
 
Fisher Scientific (Leicester, UK) 
 
Phosphate buffer 
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3.2.2 Isolation and purification of peptides with antioxidant activity from salmon skin  
 
Gelatin was extracted from salmon skin using the method in 2.2.2. GF28 was further 
isolated from the alcalase hydrolysate according to methods in 2.2.4. The peroxide 
formation inhibition activity was compared amongst the different hydrolysates as well as 
the ultrafiltration and gel filtration fractions using the ferric thiocyanate (FTC) method. 
The FTC method is described below (Section 3.2.3). 
 
3.2.3 Ferric thiocyanate (FTC) method  
 
The peroxide formation inhibition activity of samples was evaluated using the FTC 
method. The method from Kikuzaki and Nakatani (1993) with slight modifications was 
used to prepare a linoleic acid model system. Samples (20 mg) or 0.01 % (w/v) positive 
controls (ascorbate and trolox) were mixed with 10 mL absolute ethanol, 10 mL 1 M (w/v) 
phosphate buffer (pH 7.0), 4.78 mL milli-Q water and 0.12 mL linoleic acid. The mixtures 
were vortexed and kept at 40 ˚C in the dark. Samples were taken from the emulsion 
systems every 24 h to evaluate the peroxide formation inhibition activity of 
samples/control.  
 
The FTC method is based on the production of the peroxide which is the product of lipid 
peroxidation. Upon reaction with ferrous chloride, peroxide forms ferric chloride which is 
a red coloured compound. At 24 h intervals, 100 µL samples were added to a mixture of 
4.7 mL 75 % (v/v) ethanol and 100 µL 30 % (w/v) ammonium thiocyanate. Absorbance 
was read at 500 nm after the addition of 20 mM (w/v) ferrous chloride (FeCl2) to the 
mixture for 3 min. The peroxide formation inhibition activity was calculated using: 
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Peroxide formation inhibition (%) = [(C-S)/ C] x 100  
 
Where C is defined as the absorbance of control where milli-Q water is used instead of 
sample 
            S is defined as the absorbance of sample or positive controls (ascorbate and trolox) 
 
3.2.4 Antioxidant mechanisms of GF28 
 
3.2.4.1 Reducing power assay 
 
The ability of GF28 to act as a reducing agent by donating an electron or H
+
 was 
investigated using the reducing power assay by Yildirim et al. (2001) with slight 
modifications. This method was based on the reduction of ferric thiocyanate via reducing 
agents. The ferrocyanides reacted with ferric chloride to form a greenish blue compound 
known as the Perls’ Prussian Blue complex detected at 700 nm. Depending on the extent 
of reduction, the yellow colour of the reaction mixture changes to different shades of 
greenish blue mixtures depending on the amount of Perls’ Prussian Blue complex present.  
 
GF28 (1 mL) was mixed with 2.5 mL 0.2 M (w/v) phosphate buffer (pH 6.6) and 2.5 mL 
1 % (w/v) potassium ferricyanide. The concentration of GF28 used in this experiment was 
0.5-10 mg/mL). The mixture was incubated at 50 ˚C for 30 min. Followed by the addition 
of 2.5 mL 10 % (w/v) trichloroacetic acid, the mixture was centrifuged at 1,500 x g for 5 
min. In a 96 well plate, 125 µL of the supernatant was added to 125 µL milli-Q water and 
25 µL (w/v) ferric chloride. The absorbance of the solution was read at 700 nm after 10 
min. The reducing power of GF28 was expressed as the reducing power activity 
normalised to the control. The reducing power activity was calculated as follows: 
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Reducing power assay activity (%) = [(S – C)/C] x 100  
 
Where S is defined as the absorbance of samples or positive control (0.01 % BHA) 
 C is defined as the absorbance of control using 1 mL of milli-Q water instead of 
samples 
 
3.2.4.2 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity 
 
The DPPH radical is a stable water soluble radical which is characterised by its violet 
colour. When reacted with a hydrogen or electron donating agent, DPPH forms diphenyl-
picrylhydrazine (DPPH-H). Thus, the violet colour fades to a yellow colour when DPPH-H 
is formed.  
 
The method from Bersuder et al. (1998) with slight modifications was used to evaluate the 
DPPH scavenging activity of GF28. DPPH was prepared at a concentration of 0.02 % in 
ethanol (w/v). In a 96 well plate, 50 µL GF28 (0.5-10.0 mg/mL) was mixed with 50 µL 
absolute ethanol and 12.5 µL of DPPH previously prepared. The mixture was shaken and 
kept at room temperature in the dark. After 1 h, the mixture was measured at 517 nm. 
BHA (0.01 % w/v) was used as a positive control in this experiment. The DPPH radical 
scavenging activity of GF28 was calculated as follows: 
 
DPPH radical scavenging activity (%) = [(C – S)/C] x 100  
 
Where C is the absorbance of the control using 100 µL of milli-Q water instead of sample 
S is the absorbance of samples or positive control (0.01 % BHA) 
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3.2.4.3 2,2’-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical 
scavenging ability of GF28 
 
The ABTS radical scavenging method of GF28 was based on Re et al. (1999). ABTS (7 
mM) was prepared with 2.45 mM potassium persulfate. The ABTS solution was kept in 
the dark and allowed to stand in room temperature for 12 h.  Before use, ABTS solution 
was diluted with phosphate buffer (pH 7.4) until the absorbance reached 0.70 ± 0.02. GF28 
dissolved in ethanol (10 µL) was added to 1 mL prepared ABTS solution. The 
decolourisation of ABTS radicals in the presence of reducing agent was read at 734 nm 
after 5 min. The following formula was used to calculate the ABTS radical scavenging 
ability of GF28: 
 
ABTS radical scavenging activity (%) = [(C – S)/C] x 100 
 
Where C is the absorbance of control using ethanol instead of samples 
S is the absorbance of sample or positive control (0.01 % BHA)  
 
3.2.4.4 Ferrous chelating activity assay  
 
Ferrous ions form a water soluble magenta complex when reacted with ferrozine. In the 
presence of chelating agents, the formation of this Fe
2+
-ferrozine magenta complex is 
disrupted leading to the reduction of the intensity of magenta colour. Thus, the lower 
absorbance of mixtures indicates a higher chelating activity.  
 
The activity of GF28 to chelate Fe
2+
 was measured according to Dinis et al. (1994) with 
slight modifications. In a 96 well plate, 50 µL GF28 (0.5-10 mg/mL) were mixed with 160 
µL milli-Q water and 5 µL 2 mM (w/v) ferrous chloride. After 1 min, 10 µL of 5 mM (w/v) 
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ferrozine was added. The magenta complex formed was measured at 563 nm after an 
incubation period of 10 min. 0.01 % (w/v) ethylenediaminetetraacetic acid (EDTA) was 
used as a positive control. The ferrous chelating activity of GF28 was calculated as follows: 
 
Fe
2+
 chelating activity (%) = [(C – S)/C] x 100 
 
Where C is the absorbance of control using milli-Q water instead of samples 
S is the absorbance of samples or EDTA as positive control 
 
3.2.4.5 Copper ion chelating activity assay  
 
The colorimeric method from Megías et al. (2009) was modified to determine the copper 
ion chelating activity of GF28. All reagents or samples were prepared in 50 mM sodium 
acetate buffer (w/v) pH 6. GF28 (20 µL) or 0.01 % w/v EDTA (20 µL) was added to 10 
µL 1mM pyrocatechol violet (w/v) in a 96-well plate. Then, 2mM w/v copper (II) sulphate 
pentahydrate (10 µL) was added to the mixture and the absorbance read at 632 nm. 
 
The following formula was used to calculate the Cu
2+
 chelating activity: 
 
Cu
2+
 chelating activity (%) = [(C – S)/C] x 100 
 
Where C is the absorbance of control using Milli-Q water instead of samples 
S is the absorbance of samples or positive control (0.01 % EDTA) 
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3.2.5 Statistical analysis 
 
All experiments were done in triplicate (unless stated otherwise) and in three different 
experiments. Results were analysed using GraphPad Prism version 6.0. ANOVA was used 
to compare the means of the data followed by the Tukey’s post-hoc test unless stated 
otherwise. The details of the statistical tests were provided in the figure legends. A 
statistical difference was observed when p ≤ 0.05. Data were presented as mean ± SEM. 
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3.3 Results 
 
3.3.1 Purification of salmon skin gelatin peptides with peroxide formation inhibition 
activity 
 
3.3.1.1 Antioxidant activity of salmon skin gelatin digested by pepsin, collagenase and 
alcalase 
 
Peroxide formation inhibition of pepsin, collagenase and alcalase digested salmon skin 
gelatin was compared in Figure 3.1. Both positive controls, ascorbate and trolox, had a 
peroxide inhibition activity of 56.8 % and 66.1 % respectively. Salmon skin gelatin 
digested by pepsin exhibited the lowest peroxide formation inhibition activity (45.1 %) 
which was significantly lower compared to the positive controls. This was followed by the 
collagenase hydrolysate (53.8 %) where its antioxidant activity is comparable to ascorbate. 
Alcalase hydrolysate (61.6 %) showed the highest peroxide formation inhibition activity. 
Only the antioxidant activity of the alcalase hydrolysate was not significantly different to 
both ascorbate and trolox.  
 
 
 
Figure 3.1 Peroxide formation inhibition of salmon skin gelatin digested using pepsin, collagenase and 
alcalase. Ascorbate and trolox were used as positive controls. Means were compared using ANOVA followed 
by the Tukey’s post hoc test. Significant differences (p ≤ 0.05) to ascorbate and trolox were represented by a 
and b respectively. Data were expressed as mean ± SEM (n = 9). 
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3.3.1.2 Peroxide formation inhibition activity of ultrafiltration fractions  
 
As the alcalase hydrolysate exhibited the highest peroxide formation inhibition activity, 
the peptide was further purified using different MWCO cartridges. The peroxide formation 
inhibition activity of the ultrafiltration fractions are presented in Figure 3.2. The 
antioxidant activity of UF-1 (62.2 %), the fraction with the highest MW peptides, was non-
significantly different to ascorbate (57.4 %) and trolox (66.1 %). UF-2 and UF-3 exhibited 
peroxide inhibition formation activity of 65.5 % and 66.1 % respectively. Both fractions 
had similar antioxidant activity to trolox but significantly higher activity than ascorbate. 
However, there were no significant differences in the peroxide formation inhibition 
activity amongst the ultrafiltration fractions.  
 
 
 
 
 
  
Figure 3.2 Peroxide formation inhibition of ultrafiltration fractions of alcalase digested salmon skin gelatin. 
Ascorbate and trolox were used as positive controls. Means were compared using ANOVA followed by the 
Tukey’s post hoc test. Significant differences (p ≤ 0.05) to ascorbate were represented by a. Data were 
expressed as mean ± SEM (n = 9). 
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3.3.1.3 Antioxidant activity of gel filtration fractions 
 
UF-3 with the highest antioxidant activity was pooled from the ultrafiltration process and 
separated using gel filtration chromatography with a Sephadex G-25 gel to obtain peptides 
with higher purity. All gel filtration fractions collected were read at 228 nm. A higher 
absorbance indicated a higher amount of peptides in the fraction. Thus, the absorbance of 
1.0 was used as a cut-off point for the selection of fractions. Only GF28 to GF32 were 
selected and the antioxidant activity was compared using the ferric thiocyanate method as 
shown in Figure 3.3.  
 
Ascorbate and trolox were used as positive controls for this experiment. GF23 to GF32 
exhibited similar antioxidant activity to one another where GF32 (61.1 %) showed the 
lowest activity. Apart from GF 32, GF23 to GF31 exhibited significantly higher 
antioxidant activity compared to ascorbate (56. %). GF 32 also showed significantly lower 
antioxidant activity than trolox (67.3 %). Fractions with highest peroxide formation 
inhibition activity were GF26 (67.3 %), GF27 (68.8 %) and GF28 (67.1 %).  
 
Although the peroxide formation inhibition activity of GF23 to GF32 were similar, only 
GF28 showed significantly higher ACE inhibition activity in Chapter 1. Thus, GF28 was 
chosen for further studies in the elucidation of its antioxidant mechanisms.  
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Figure 3.3 Peroxide formation inhibition of UF-3 gel filtration fractions. Ascorbate and trolox were used as 
positive controls. Means were compared using ANOVA followed by the Tukey’s post hoc test. Significant 
differences (p ≤ 0.05) to ascorbate and trolox were represented by a and b respectively. Data were expressed 
as mean ± SEM (n = 9). 
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3.3.2 Antioxidant mechanisms of GF28 
 
3.3.2.1 Reducing power assay of GF28 
 
The reducing power assay of 0.5 to 20.0 mg/mL GF28 was investigated in Figure 3.4. 
This assay is based on the detection of the Perls’ Prussian Blue complex at 700 nm. In the 
presence of reducing agents, ferric thiocyanate is reduced to the ferrous form. The addition 
of FeCl3 forms the ferrous-ferric complex known as the Perls’ Prussian Blue complex.  
 
BHA was used as a positive control which acts as an efficient reducing agent. Thus, the 
reducing power assay activity was shown to be 69.0 %. A gradual increase in reducing 
power assay activity was observed (0.9 % to 9.8 %) in 0.5 to 10.0 mg/mL GF28. However, 
all concentrations were shown to have a significantly lower reducing power activity than 
BHA. Reducing power assay activity of 10.0 mg/mL GF28 (9.8 %) was significantly 
higher than the other concentrations used apart from 7.5 mg/mL GF28 (8.2 %). 
 
 
 
  
Figure 3.4 Reducing power assay of 0.5 to 10.0 mg/mL GF28. The formation of Perls’ Prussian Blue 
complex was detected at 700 nm. A significant difference (p < 0.05) to the positive control, BHA, was 
represented by a. Means were compared using ANOVA followed by the Tukey’s post hoc test. Data 
correspond to the mean ± SEM (n = 9). 
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3.3.2.2 DPPH radical scavenging activity 
 
Figure 3.5 showed the DPPH radical scavenging activity of 0.5 to 10.0 mg/mL GF28 
compared to BHA as a positive control. GF28 showed very low DPPH radical scavenging 
activity where the highest concentration used, 10.0 mg/mL GF28, only showed 3.5 % 
activity.  
 
 
  
 
  
Figure 3.5 DPPH scavenging activity of 0.5 to 10.0 mg/mL GF28. Activity was measured at 517 nm and 
compared to 0.02 % BHA as a natural antioxidant. Means were compared using ANOVA followed by the 
Tukey’s post hoc test. Data correspond to the mean ± SEM (n = 9). A significant difference (p < 0.05) to the 
positive control, BHA, was represented by a. 
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3.3.2.3 ABTS assay 
 
In this assay, ABTS is generated and the decolourisation of this blue green molecule is 
detected at 734 nm. The ABTS radical scavenging activity of GF28 compared to BHA as a 
positive control is shown in Figure 3.6. ABTS radical scavenging activity exhibited by 
GF28 was significantly lower than BHA (75.5 %). There was only a slight increase in 
ABTS radical scavenging activity when the concentration of GF28 increased. The highest 
ABTS radical scavenging activity exhibited in GF28 (10.0 mg/mL) was 4.5 %.  
 
 
 
  
 
 
  
Figure 3.6 ABTS radical scavenging activity of 0.5 to 10.0 mg/mL GF28. Activity was measured at 734 nm 
compared to 0.02 % BHA as a natural antioxidant. Means were compared using ANOVA followed by the 
Tukey’s post hoc test. A significant difference (p < 0.05) to the positive control, BHA, was represented by a. 
Data correspond to the mean ± SEM (n = 9). 
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3.3.2.4 Fe
2+
 chelating activity assay 
 
In Figure 3.7, the chelation activity of GF28 increased in a dose dependent manner with 
the concentration used. EDTA is an effective metal chelator, the ferrous chelating activity 
was 84.1 %. Ferrous chelating activity of 2.5 mg/mL GF28 (68.7 %) was not significantly 
different to EDTA (84.1 %). GF28 reached maximum ferrous chelating activity at 5.0 
mg/mL (87.0 %). Further increase in GF28 concentration to 7.5 and 10.0 mg/mL did not 
significantly increase the ferrous chelation activity (90.0 % and 90.0 % respectively). IC50 
of GF28 was determined to be 1.0 mg/mL.  
 
 
 
 
 
 
  
Figure 3.7 Ferrous chelating activity of 0.5 to 10.0 mg/mL GF28 compared to 0.02 % EDTA as a positive 
control. Means were compared using ANOVA followed by the Tukey’s post hoc test. A significant difference 
(p ≤ 0.05) to EDTA was represented by a.  Data correspond to the mean ± SEM (n = 9). 
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3.3.2.5 Cu
2+
 chelating activity assay 
 
Similar to the ferrous chelating activity assay, the copper chelating activity assay is shown 
to be proportional to the concentration of GF28 used (Figure 3.8). The copper chelating 
activity of GF28 increased from 1.6 % to 58.1 % when concentrations used increased from 
0.5 to 10.0 mg/mL. However, the highest concentration of GF28 used, 10.0 mg/mL, had 
significantly lower copper chelating activity than EDTA (58.1 % and 86.3 % respectively). 
IC50 of GF28 was also shown as 7.6 mg/mL. The activity of 10.0 mg/mL GF28 was not 
significantly higher than 7.5 mg/mL GF28 (50.3 %). 
 
 
 
 
 
 
  
Figure 3.8 Copper chelating activity of 0.5 to 10.0 mg/mL GF28 compared to 0.02 % EDTA as a positive 
control. Means were compared using ANOVA followed by the Tukey’s post hoc test. A significant 
difference (p ≤ 0.05) to EDTA was represented by a.  Data correspond to the mean ± SEM (n = 9). 
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3.4 Discussion 
 
3.4.1 Purification of salmon skin gelatin with antioxidant activity 
 
The antioxidant activity of salmon skin gelatin hydrolysed by different enzymes as well as 
the further purified protein fractions were evaluated in their peroxide formation inhibition 
activity using the FTC method. Ascorbate and trolox were used as positive controls in the 
experiments as both are commercially used antioxidants in food products. Ascorbate acts 
as a potent electron donor and trolox is the water soluble analogue of Vitamin E.  
 
Gelatin was extracted from salmon skin and digested using pepsin, collagenase and 
alcalase and their antioxidant activity was compared in Figure 3.1. Pepsin digested 
hydrolysate (45.1 %) exhibited the lowest antioxidant activity. The alcalase hydrolysate 
exhibited the highest peroxide formation inhibition (61.6 %) which was not significantly 
different to the activity of ascorbate and trolox (56.8 % and 66.1 % respectively). As 
discussed in 2.4.1, the higher activity of the alcalase hydrolysates may be due to the 
enzyme alcalase exists as a crude enzyme of several proteases which have different 
cleavage sites. This can lead to a greater degree of hydrolysis and the production of more 
bioactive peptides.  
 
Alcalase hydrolysate was subjected to further purification using ultrafiltration cartridges 
with different MWCO. Antioxidant activity of UF-2 (65.5 %) and UF-3 (66.1 %) were 
similar. Apart from that, the peroxide formation inhibition activities of UF-2 and UF-3 
were also significantly higher than ascorbate (57.4 %). However, compared to the alcalase 
hydrolysate (61.6 %), there was only a slight increase in antioxidant activity of 
ultrafiltration fractions. UF-3 was further purified by gel filtration column using Sephadex 
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G25 gel. In Figure 3.3, GF23 to GF32 exhibited peroxide formation inhibition activity that 
was not significantly different to one another. This is in contrary to some studies that the 
antioxidant activity of peptides significantly increased with the reduction of MW such as 
soy protein fractions (Moure et al., 2006) and cod (Farvin et al., 2014). However, GF28 
was chosen for further studies as only this fraction showed significantly higher ACE 
inhibition activity (Chapter 2) than the others.  
 
3.4.2 Antioxidant mechanisms of GF28 
 
GF28 exhibited low reducing power activity (Figure 3.4) where 10 mg/mL GF28 showed 
9.8 % reducing power activity when normalised to control. Both DPPH and ABTS radical 
scavenging activity assay measure the ability of GF28 peptide to act as an electron donor 
or hydrogen donor. DPPH exists as a lipid soluble radical whereas ABTS as a water 
soluble radical. GF28 also showed minimal DPPH and ABTS radical scavenging abilities 
(Figure 3.5 and Figure 3.6 respectively). GF28 (10 mg/mL) showed DPPH and ABTS 
radical scavenging activity of 3.5 % and 4.5 % respectively. This indicated that GF28 was 
not efficient as an antioxidant that scavenges free radicals either in a hydrophobic or 
hydrophilic environment.   
 
Transition metal ions react with lipid hydroperoxides to form alkoxyl readicals (Repetto et 
al., 2010). Alkoxyl radicals are highly reactive and can propagate lipid peroxidation. Thus, 
the inhibition of transition metal ions could decrease lipid peroxidation. GF28 exhibited 
high chelation activity of iron and copper transition ions (Figure 3.7 and Figure 3.8). The 
GF28 for the IC50 of Fe
2+
 and Cu
2+
 were 1.0 and 7.6 mg/mL respectively.  
 
It was observed that the chelation activity was the main antioxidant mechanism of GF28. 
GF28 also showed low reducing power activity as well as non-significant DPPH and 
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ABTS radical scavenging abilities. Most studies revealed that marine sourced peptides 
such as patin (Najafian and Babji et al., 2015) and croceine croaker (Chi et al., 2015) 
exhibited high DPPH and ABTS radical scavenging ability which may be attributed to the 
high amount of hydrophobic and aromatic amino acids of the peptides. This was contrary 
to the findings of this study and suggests that the amount of hydrophobic and aromatic 
amino acids is less important than the sequence of the peptide in its antioxidant 
mechanisms. The amount of Cys, His, Asp and Glu in GF28 (8.1 %) may play a role in the 
chelation activity of the peptide as the amino acids above are shown to be responsible for 
the metal chelating activity of peptides in Guo et al. (2015). Histidine also contributes to 
the metal chelating activity of peptides where the imidazole ring was shown to form 
copper chelates to retard copper mediated lipid oxidation (Torres-Fuentes et al., 2014). 
Histidine only accounted for 2.1 % of GF28. Pownall et al. (2010) also showed that 
peptides that exerted the highest metal chelation activity had low amounts of histidine; this 
study also showed that the metal chelation activities were associated with  hydrophobic 
amino acids which can be found in high amounts in GF28 (28.3 %). 
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3.5 Conclusion 
 
Gelatin was successfully extracted from salmon skin and digested with pepsin, collagenase 
and alcalase. The alcalase hydrolysate exhibited the highest peroxide formation inhibition 
and was chosen for further purification using ultrafiltration and gel filtration 
chromatography. The purified fractions were compared in terms of their antioxidant 
activity by measuring the peroxide formation inhibition using FTC. It was shown that a 
decrease in MW of the peptide did not significantly increase the peroxide formation 
inhibition activity. The antioxidant activities of the ultrafiltration as well as gel filtration 
fractions were not significantly different to the alcalase hydrolysate. However, GF28 was 
still chosen for further studies as it exhibited the highest ACE inhibition amongst the 
fractions. 
 
The main antioxidant mechanism of GF28 was chelation of transition metal ions such as 
Fe
2+ 
and Cu
2+
. However, GF28 showed low reducing power activity. The ABTS and 
DPPH radical scavenging activities were poor in GF28. This indicated that GF28 have low 
scavenging activity of both water and lipid soluble radicals. The amino acid analysis of 
GF28 (Section 2.3.3) indicated that the amount of hydrophobic amino acids (28.3 %) and 
aromatic amino acids (9.4 %) may contribute to the antioxidant mechanisms of the peptide. 
However, the sequence of the amino acids may also be essential to the antioxidant 
mechanisms of bioactive peptides. 
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Chapter 4 
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4 EFFECT OF GF28, A SALMON SKIN GELATIN PEPTIDE, ON 
THE ENDOGENOUS ANTIOXIDANT DEFENCE SYSTEM IN HEPG2 
CELLS 
 
4.1 Introduction 
 
According to the NHS (2014), cancer is defined as the condition where the cells in a 
certain part of the body, divide and grow uncontrollably.  In the UK, liver cancer accounts 
for 1 % of all cancer and 3 % of deaths due to cancer (Cancer Research UK, 2015a). Liver 
cell cancers account for approximately half of the liver cancers followed by intrahepatic 
bile duct carcinomas and unspecified types (West et al., 2006). The majority of liver cell 
cancers are hepatocellular carcinoma.  
 
Reactive oxygen species (ROS) are produced resulting from normal cellular metabolism 
and xenobiotic detoxification. Although low to moderate amounts of ROS are essential, an 
excess of ROS (defined as oxidative stress) can lead to DNA, lipid and protein damage in 
cells. Oxidative stress is linked to the development and progression of ageing, cancer, 
diabetes and cardiovascular diseases (Valko et al., 2007). Oxidative stress is considered to 
be highly involved in the pathogenesis of cancer (Valko et al., 2006; Sosa et al., 2013). 
Thus, the homeostasis between the production and elimination of ROS is essential for the 
normal function of cells.  
 
In response to oxidative stress, the endogenous antioxidant defence system of the body is 
involved in the removal and elimination of ROS in the body. The liver is the second largest 
organ in the body; one of the main functions of the liver is the detoxification of alcohol 
and toxins in the body.  
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As the liver is the main detoxification organ of the body, the endogenous antioxidant 
defence systems such as superoxide dismutase (SOD), glutathione peroxidase (GPx), 
glutathione reductase (GR) and catalase are crucial. Lower levels of GPx and GSH were 
found in liver cancer patients (Arslan et al., 2014). SOD expression was also shown to 
increase in cancerous cell lines (Liu et al., 2012; Chen et al., 2014). 
 
Recent studies of bioactive peptides showed growth inhibition effects on cancer cell lines. 
Many marine sourced bioactive peptides exerted anti-proliferative effects on different 
types of cancer cell lines such as half-fin anchovy on prostate cancer cells (Song et al., 
2014), tuna on breast cancer cell cells (Hung et al., 2014) and loach on colon cancer cells 
(You et al., 2011).  However, only one study regarding the effect of bioactive peptides 
(from rice bran) on liver cancer cells was found (Kannan et al., 2010).  
 
Thus, GF28 was isolated and purified from salmon skin gelatin and its effect on HepG2 
cells, a human hepatocellular carcinoma cell line, was investigated. Using the MTT assay, 
the anti-proliferative effect and IC50 of GF28 was determined. In addition, the effect of 
GF28 on the different endogenous antioxidant defence systems of HepG2 cells was 
investigated. These included SOD, catalase, GSH, GPx and GR. 
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4.2 Methods 
 
4.2.1 Materials and reagents 
 
The following materials and reagents were purchased from the different suppliers: 
 
 
Materials 
 
Supplier 
 
HepG2 cell line 
 
 
Sigma-Aldrich (Dorset, UK)  
Thiazolyl blue tetrazolium bromide 
 
Dimethyl sulfoxide (DMSO) 
 
Dulbecco’s Modified Eagle Medium 
(Gibco) 
 
 
 
 
 
Fisher Scientific (Leicester, UK) 
 
Foetal Bovine Serum (Gibco) 
 
Penicilin-streptomycin (Gibco) 
 
L-Glutamine 200 mM (Gibco) 
 
1x Trypsin (Gibco) 
 
Phosphate buffer saline pH 7 (Gibco) 
 
Non-essential amino acid (Gibco) 
 
Glutathione peroxidase assay kit 
 
 
Cambridge Bioscience Ltd (Cambridge, 
UK) 
 
Glutathione reductase assay kit 
 
OxiSelect Total Glutathione Assay Kit 
 
Amplex Red Catalase Assay Kit 
 
Abcam (Cambridge, UK) 
 
Superoxide Dismutase Activity Assay Kit 
(colorimetric)  
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4.2.2 Extraction and isolation of GF28 
 
Gelatin was extracted from salmon skin using the method in 2.2.2. GF28 was then further 
isolated from the alcalase hydrolysate according to methods in 2.2.4.  
 
4.2.3 Cell culture  
 
HepG2 cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10 % foetal bovine serum, 1 % penicillin-streptomycin, 1 % non-essential amino acid 
and 1 % L-glutamine. Cells were sub-cultured when cells were 80 % confluent using 1 mL 
(25 cm
2 
flasks) or 2 mL (75 cm
2
 flasks) 0.01 % trypsin after washing with 5 mL phosphate 
buffer saline pH 7. Seeded cells were incubated at 37 ˚C in a 5 % CO2 humidified 
incubator. HepG2 cells were obtained from Sigma-Aldrich at Passage 48 (P 48). HepG2 
P48 to P60 were used in the experiments below.  
 
4.2.4 Effect of GF28 on the cell viability of HepG2 cells (MTT assay) 
 
The MTT assay was used to measure the number of viable cells using the tetrazolium dye 
thiazolyl blue tetrazolium bromide (MTT). Oxidoreductase enzymes found in viable cells 
will reduce the MTT dye to a purple insoluble formazan. Thus, the higher intensity of the 
purple colour reflects a higher number of viable cells present.  
 
For this assay, cells were cultured in 96-well tissue culture plates at 1 x 10
4
 cells/ 100 µL 
for each well. After 24 h when cells were 50 % confluent, 100 µL of a concentration range 
of GF28 (0.05-1.00 mg/mL) was used to treat the cells for another 24 h. Then, 20 µL MTT 
dye prepared at 5 mg/mL in phosphate buffer saline (PBS) was added to each individual 
wells and incubated in 37 ˚C and 5 % CO2 humidified incubator. 
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After a 2 h incubation period, the culture medium and MTT dye mixture was aspirated and 
100 µL dimethyl sulfoxide (DMSO) was further added to the wells to solubilise the 
formazan crystals. The 96-well tissue culture plate was shaken for 3 min at room 
temperature and the intensity of the purple colour was measured at 570 nm using a plate 
reader (FLUOstar Omega, BMG Labtech).   
 
Cells treated with just media were used as control. Each sample was repeated 6 times and 
the experiment was also repeated on three different separate occasions to ensure 
reproducibility. Cell viability (%) was calculated using the following formulae: 
 
Cell viability (%) = 100 – [[(C-S)/ C] x 100] 
 
Where C is defined as the absorbance of control (treated with media only) at 570 nm 
S is defined as the absorbance of samples (treated with GF28) at 570 nm 
 
4.2.5 Effect of GF28 on HepG2 cell morphology 
 
HepG2 cells were seeded at 1 x 10
6
 cells/ 5 mL in 25 cm
2
 cell culture flasks and incubated 
for 24 h. When cells were 50 % confluent, different concentrations (0.100, 0.150 and 0.175 
mg/mL) of GF28 were added to individual flasks and incubated for another 24 h in a 
humidified incubator (37 ˚C, 5 % CO2). Changes in cell morphology were observed under 
a phase contrast microscope fitted with a camera (Nikon Eclipse TS100) at a magnification 
of  10 x. 
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4.2.6 Effect of GF28 on the endogenous antioxidant defence system 
 
4.2.6.1 Collection of cell lysate 
 
HepG2 cells were seeded at 1 x 10
6
 cells/5 mL in 25 cm
2
 cell culture flasks for 24 h. When 
cells were 50 % confluent, different concentrations (0.100, 0.150 and 0.175 mg/mL) of 
GF28 were added to individual flasks and incubated for another 24 h in a humidified 
incubator (37 ˚C, 5 % CO2). The media solution of the flasks were aspirated and washed 
with 3 mL phosphate buffer solution. Cold PBS (1 mL) was added and the cells were 
collected using a rubber policeman. The solution was collected in an eppendorf and 
centrifuged for 10,000 x g for 3 min. Then, the supernatant containing the cell lysate was 
collected and stored at -80 ˚C for further use. Cell lysates from flasks treated with media 
alone were also used as control.  
 
4.2.6.2 Superoxide dismutase activity assay 
 
The superoxide dismutase (SOD) activity of HepG2 cell lysate was determined according 
to the manufacturer’s instructions using the Superoxide Dismutase Activity Assay Kit 
(Colorimetric). This assay was based on the reduction of a superoxide anion (O2
.
); the 
reagent WST-1 produces a water-soluble formazan upon O2
. 
reduction. The absorbance of 
the water-soluble formazan was read at 450 nm. However, the rate of reduction of O2
.
 
using WST-1 was inhibited by SOD. Thus, higher absorbance indicated lower SOD 
activity. Cell lysates collected in 4.2.6.1 were used in this experiment. All samples were 
run in triplicate and the experiment was also repeated on three separate occasions.  
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4.2.6.3 Catalase assay 
 
The effect of GF28 on the catalase activity in HepG2 cells was further investigated. The 
experiment was conducted according to the manufacturer’s instructions. Catalase reacts 
with H2O2 to produce water and oxygen. This assay is based on the production of resorufin. 
In the presence of horse radish peroxidase, the Amplex Red reagent reacts with excess 
H2O2 to produce resorufin. Resorufin is detected at 560 nm in a plate reader. Thus, a 
higher amount of resorufin produced reflected lower catalase activity. Cell lysates 
collected in 4.2.6.1 were used in this experiment. All samples were run in triplicate and the 
experiment was also repeated in three separate occasions.  
 
4.2.6.4 Total glutathione assay 
 
Total glutathione was quantified according to the instructions in the OxiSelect Total 
Glutathione Assay Kit. Glutathione reductase (GR) was used to reduce oxidised 
glutathione (GSSG) to the reduced form (GSH). Then, the thiol found in GSH reacts with 
the chromogen to produce a coloured compound with an absorbance at 405 nm. Thus, 
higher amounts of GSH and GSSG lead to a higher absorbance at 405 nm. Cell lysates 
collected in 4.2.6.1 were used in this experiment. All samples were run in triplicate and the 
experiment was also repeated on three separate occasions.  
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4.2.6.5 Glutathione peroxidase assay 
 
The glutathione peroxidase (GPx) activity of cell lysates prepared in 4.2.6.1 was 
determined in accordance to the kit’s instructions. In the presence of hydroperoxides, 
glutathione peroxidase (GPx) oxidises GSH to GSSG. Then by oxidising NADPH to 
NADP
+
, glutathione reductase (GR) recycles GSSG into the reduced form. The kit was 
based on the reduction of absorbance at 340 nm when NADPH was oxidised to NADP
+
. 
The reduction of absorbance was proportional to the GPx activity. All samples were run in 
triplicate and the experiment was further repeated on three separate occasions. 
 
4.2.6.6 Glutathione reductase assay 
 
Similar to the principle in 4.2.6.5, the GR activity of cell lysates from 4.2.6.1 was based on 
the reduction of absorbance at 340 nm when NADPH oxidised to NADP
+
. The reduction 
in absorbance was proportional to the GR activity. All samples were run in triplicate and 
the experiment was repeated on three separate occasions. 
 
4.2.7 Statistical analysis 
 
All experiments were done in triplicate (unless stated otherwise) and on three different 
occasions. Results were analysed using GraphPad Prism version 6.0. ANOVA was used to 
compare the means of the data followed by the Tukey’s post-hoc test unless stated 
otherwise. The details of the statistical tests were provided in the figure legends. A 
statistical difference was observed when p ≤ 0.05. Data were presented as mean ± SEM. 
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4.3 Results 
 
4.3.1 Cell viability assay of HepG2 
 
The effect of GF28 on the cell viability of HepG2 cells was investigated using the MTT 
assay. HepG2 cells were treated with 0.05-1.0 mg/mL GF28 for 24 h. Figure 4.1 showed 
that GF28 exhibited anti-proliferative effects on HepG2. The cell viability of HepG2 was 
also inversely correlated to the concentration of GF28. Marked reduction in the cell 
viability was observed in HepG2 treated with 0.125 mg/mL GF28 (67.9 %). Cell viability 
was also shown to significantly decrease with increased GF28 starting from 0.125-1.000 
mg/mL compared to untreated cells. IC50 of GF28 on HepG2 cells was determined to be 
0.154 mg/mL. Based on the results obtained, the concentrations of GF28 used for further 
studies were determined to be 0.100, 0.150 and 0.175 mg/mL respectively. 
 
 
 
 
 
Figure 4.1 Cell viability of HepG2 cells treated with GF28 for 24 h. HepG2 cells were cultured and 
incubated with GF28 over a concentration range of 0.05-1.00 mg/mL respectively. Means were compared 
using ANOVA followed by the Tukey’s post hoc test. A significant difference (p ≤ 0.05) to the cell viability 
of untreated cells was represented by a.  Data correspond to the mean ± SEM (n = 18). 
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4.3.2 Effect of GF28 on the morphology of HepG2 cells  
 
Figure 4.2 shows the cell morphology of HepG2 cells treated with 0.100, 0.150 and 0.175 
mg/mL GF28 respectively. The morphology of the GF28-treated cells were compared to 
the untreated HepG2 cells using light microscopy at 10 x magnification. The morphology 
of cells treated with 0.100 mg/mL showed no significant difference to the untreated cells. 
On the other hand, it can be observed that increase in GF28 concentration increased 
HepG2 cell death under the microscope. 0.150 mg/mL GF28-treated cells showed small 
amount of dead cells whilst 0.175 mg/mL GF28-treated cells showed greater amount of 
unhealthy or dead cells than the smaller GF28 concentrations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 4.2 Morphology of HepG2 cell line in (A) untreated cells, (B) cells treated with 0.100 mg/mL GF28, 
(C) cells treated with 0.150 mg/mL GF28 and (D) cells treated with 0.175 mg/mL GF28. HepG2 cells were 
incubated with the treatments above for 24 h and observed under light microscope. Images captured were at 
10 x magnification. 
(A) (B) 
(C) (D) 
10 x 10 x 
10 x 10 x 
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4.3.3 Effect of GF28 on endogenous antioxidant defence system 
 
4.3.3.1 Superoxide dismutase (SOD) activity 
 
Superoxide dismutase activity of untreated cells as control as well as cells treated with a 
concentration range of GF28 (0.100, 0.150 and 0.175 mg/mL) was shown in Figure 4.3. 
SOD activity of 0.100 mg/mL GF28-treated cells was similar to the control (70.2 % vs 
73.5 %). 0.150 and 0.175 mg/mL GF28-treated cells (60.4 % and 46.2 % respectively) 
showed significantly lower SOD activities than the control. Thus, it can be observed that 
an increase in GF28 concentration reduces the SOD activity in HepG2 cells.  
 
 
 
 
 
 
 
 
 
Figure 4.3 Superoxide dismutase activity of HepG2 cells treated with GF28 for 24 h. HepG2 cells were 
cultured and incubated with GF28 of 0.100, 0.150 and 0.175 mg/mL respectively. HepG2 cells incubated 
with media alone were used as control. Means were compared using ANOVA followed by the Tukey’s post 
hoc test. A significant difference (p ≤ 0.05) to the SOD activity of the control was represented by a.  Data 
correspond to the mean ± SEM (n = 9). 
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4.3.3.2 Effect of GF28 on the activity of catalase in HepG2 cells 
 
The activity of catalase in HepG2 cells subjected to different treatments of GF28 was 
presented in Figure 4.4. The catalase activity in untreated cells (control) shown was 41.8 
mU. There was no significant change in catalase activity when cells were treated with 
0.100 mg/mL GF28 (47.9 mU). A significant increase of the catalase activity compared to 
the control was also observed in 0.150 mg/mL (70.5 mU) and 0.175 mg/mL (77.0 mU) 
GF28-treated cells. However, there was no significant difference in the activity of catalase 
between the two concentrations of GF28-treated cells (0.150 mg/mL and 0.175 mg/mL).  
 
 
 
 
  
 
 
  
  
Figure 4.4 The catalase activity in HepG2 cells treated with GF28 for 24 h. HepG2 cells were cultured and 
incubated with GF28 of 0.100, 0.150 and 0.175 mg/mL respectively. HepG2 cells incubated with media 
alone were used as control. Means were compared using ANOVA followed by the Tukey’s post hoc test. A 
significant difference (p ≤ 0.05) to the activity of catalase in the control was represented by a.  Data 
correspond to the mean ± SEM (n = 9). 
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4.3.3.3 Effect of GF28 on the total amount of glutathione 
 
The total amount of glutathione in untreated cells was 5.4 µM (Figure 4.5). A significant 
reduction of the amount of total glutathione was observed in cells treated with GF28. The 
total glutathione amount in 0.100 mg/mL GF28-treated cells was 3.3 µM and followed by 
0.150 mg/mL (1.9 µM). Cells treated with 0.175 mg/mL GF28 showed the lowest amount 
of total glutathione (1.0 µM). Thus, it was shown that the amount of total glutathione was 
inversely correlated to the GF28 concentration used to treat HepG2 cells.  
 
 
 
  
 
 
 
 
 
 
 
Figure 4.5 The amount of total glutathione in HepG2 cells treated with GF28 for 24 h. HepG2 cells were 
cultured and incubated with GF28 of 0.100, 0.150 and 0.175 mg/mL respectively. HepG2 cells incubated 
with media alone were used as control. Means were compared using ANOVA followed by the Tukey’s post 
hoc test. A significant difference (p ≤ 0.05) to the amount total glutathione in the control was represented by 
a.  Data correspond to the mean ± SEM (n = 9). 
 100 
 
4.3.3.4 Effect of GF28 on glutathione peroxidase (GPx) activity of HepG2 cells 
 
The glutathione peroxidase (GPx) activity of HepG2 cells decreased when the 
concentration of GF28 used increased (Figure 4.6). GPx activity of untreated cells were 
normalised to 50 %. GPx activity of HepG2 cells treated with the range of GF28 (0.100, 
0.150 and 0.175 mg/mL) were significantly lower than the control.  On the other hand, the 
GPx activity of 0.175 mg/mL GF28-treated cells showed approximately half the activity of 
untreated cells (27.4 % vs 50.0 %).  
 
 
 
  
 
 
 
 
  
 
 
Figure 4.6 Glutathione peroxidase activity normalised to the control in HepG2 cells treated with GF28 for 24 
h. HepG2 cells were cultured and incubated with GF28 of 0.100, 0.150 and 0.175 mg/mL respectively. 
HepG2 cells incubated with media alone were used as control. Means were compared using ANOVA 
followed by the Tukey’s post hoc test. A significant difference (p ≤ 0.05) to the glutathione peroxidase 
activity in the control was represented by a.  Data correspond to the mean ± SEM (n = 9). 
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4.3.3.5 Effect of GF28 on glutathione reductase (GR) activity of HepG2 cells 
 
Figure 4.7 presented the glutathione reductase (GR) activity of HepG2 cells treated with a 
range of GF28 concentrations (0.100, 0.150 and 0.175 mg/mL). GR activity of untreated 
cells (control) was normalised to 50 %. It was shown that GF28 did not affect the GR 
activity in HepG2 cells. All GF28-treated cells showed similar GR activity to the control.  
 
 
 
 
 
 
  
Figure 4.7 Glutathione reductase activity normalised to the control in HepG2 cells treated with GF28 for 24 
h. HepG2 cells were cultured and incubated with GF28 of 0.100, 0.150 and 0.175 mg/mL respectively. 
HepG2 cells incubated with media alone were used as control. Means were compared using ANOVA 
followed by the Tukey’s post hoc test. Data correspond to the mean ± SEM (n = 9). 
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4.4 Discussion 
 
4.4.1 Effect of GF28 on cell viability assay and morphological changes in HepG2 cell 
line 
 
HepG2 cells were incubated with a concentration range of GF28 for 24 h and the cell 
viability was determined using the MTT assay. GF28 exhibited anti-proliferative effects on 
HepG2 cells where cell death increased with increasing concentration of GF28. The effect 
of GF28 on HepG2 cells was observed under a light microscope. A visible amount of dead 
cells was also observed for 0.175 mg/mL GF28-treated cells when compared to 0.150 
mg/mL. 
 
4.4.2 Effect of GF28 on the endogenous antioxidant defence system 
 
Superoxide dismutase plays an essential role in the antioxidant defence system whereby 
SOD converts superoxide radicals (O2
-
) to hydrogen peroxide (H2O2). It was found that 
SOD expression in HepG2 cells was twice the amount when compared to normal cells 
(Hanif et al., 2005). Clavijo-Cornejo et al. (2014) found that the transiently impaired SOD 
can be rapidly recovered in HepG2 cells. This may pose as a survival advantage in cancer 
cells and SOD can be considered as a target for liver cancer.  The inhibition of SOD in 
cancerous cells may induce the accumulation of O2
-
 and lead to reactive oxygen species 
(ROS) induced cellular damage and apoptosis (Huang et al., 2000). In Figure 4.3, GF28 
reduced SOD activity in HepG2 cell line. An increase in GF28 concentration also led to 
the decrease in SOD activity. SOD activity in 0.175 mg/mL treated cells was 
approximately half the activity in control.   
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Characterised by the different redox active metals in their catalytic sites, SOD also exists 
as different isotypes. The cystolic and mitochondrial SOD are major enzymes in the 
antioxidant defence system. Cystolic SOD contains copper/zinc whereas mitochondrial 
SOD contains manganese. In Chapter 3, GF28 was shown to be a very effective metal 
chelator. GF28 would be able to bind to the metal ion in the catalytic site of SOD. This 
would then able to reduce the SOD activity.  
 
 Catalase catalyses the conversion of H2O2 produced by SOD to water and oxygen. It was 
expected that the reduction in SOD activity would reduce H2O2 and thus the catalase 
activity. However, the opposite was observed in Figure 4.4 where the catalase activity 
increased when SOD activity decreased with increasing GF28 concentration. Apart from 
SOD, other enzymatic systems in different cellular compartments including sulfhydryl 
oxidase in the endoplasmic reticulum (ER) as well as amino acid oxidases and lipid 
oxygenase in the cytosol can generate H2O2 (Giorgio et al., 2007). A possible explanation 
for the results may be the inhibition of SOD by GF28 that can lead to the accumulation of 
ROS which induced ER stress (Qu et al., 2013). ER stress further activates the unfolded 
protein response (UPR) which also leads to the increase of protein folding capacity in the 
ER (Wang and Kaufman, 2014). In the ER, sulfhydryl oxidases are responsible for 
oxidising sulfhydryl groups to form disulphide bonds in the folding of proteins. The 
formation of disulphide bonds via sulfhydryl oxidases produces H2O2 (Faccio et al., 2011). 
Thus, the increased ER stress induced by GF28 causes UPR which increases H2O2 
production.  The increased amount of H2O2 produced may lead to the increase of catalase 
activity seen in Figure 4.4.  
 
Glutathione (GSH) is a tripeptide responsible for preventing the ROS damage of cellular 
components.  The thiol group of the cysteine in GSH acts as a reducing agent which 
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inactivates ROS and produces oxidised glutathione (GSSG).  The amount of total 
glutathione in HepG2 cells are inversely correlated with GF28 concentration (Figure 4.5). 
As glutathione is an essential component in the endogenous antioxidant defence system, 
the enzymes involved in glutathione metabolism are important. GPx are selenoproteins 
responsible for the conversion of GSH to GSSG whilst reducing lipid hydroperoxides to 
alcohols or H2O2 to water and oxygen (Görlach, 2014). On the other hand, GR is an 
important enzyme that catalyses the conversion of GSSG to GSH to regenerate the 
antioxidant activity of GSH. GPx activity of GF28-treated HepG2 cells was significantly 
lower than the control (Figure 4.6) whereas GF28 had no effect on GR activity (Figure 
4.7).   
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4.5 Conclusion 
 
GF28 is a peptide derived from salmon (Salmo salar) skin gelatin and exhibited anti-
proliferative effects on HepG2 cells.  MTT results showed significantly lower cell viability 
in 0.125 mg/mL GF28-treated HepG2 cells. IC50 of GF28 was also determined to be 0.154 
mg/mL. Under the light microscope, similar results can be observed where increased 
HepG2 cell death was observed with increasing GF28 concentration. 
 
The effect of GF28 on the endogenous antioxidant system of HepG2 cells was also 
investigated. SOD activity was significantly decreased in 0.150 mg/mL GF28-treated cells. 
As GF28 was shown to exhibit effective metal chelation activity in the previous chapter, 
GF28 may be able to inhibit the redox active metals in the catalytic site of SOD and thus 
the SOD activity. As SOD was also found to be higher in cancerous cells, the inhibition of 
SOD activity of GF28 could be considered as a target for liver cancer treatment.  
 
However, the activity of catalase increased in spite of the decreased H2O2 due to a 
reduction in SOD activity with GF28. This may be due to GF28 that is able to induce UPR 
via ER stress and the increased protein folding in the ER with sulfhydryl oxidases would 
increase H2O2 production. Thus, sulfhydryl oxidase in the increased protein folding posed 
as an alternative source of H2O2 apart from SOD causing the increase in catalase activity.  
 
GF28 also affected the endogenous antioxidant system by decreasing the amount of total 
glutathione and GPx activity. Apart from that, the GR activity was unchanged in GF28-
treated HepG2 cells.  
 
In conclusion, GF28 was able to inhibit proliferation of hepatocellular carcinoma. The 
anti-proliferation activity of GF28 may be attributed to the effective inhibition of SOD 
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which was speculated to be an effective target for liver cancer treatment. The decrease of 
GSH and GPx activities by GF28 may also contribute to its anti-proliferative activity in 
HepG2 cells. However, more in vitro as well as in vivo research is needed. 
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Chapter 5 
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5 ANTI-PROLIFERATIVE EFFECT AND MECHANISMS OF GF28 
ON HUMAN COLORECTAL ADENOCARCINOMA CELLS 
 
5.1 Introduction 
 
Colorectal cancer is the fourth most common cancer that occurs in the UK and accounts 
for 13 % of all cancer cases (Cancer Research UK, 2011). Colorectal cancer is also known 
as bowel cancer which includes colon cancer and rectal cancer depending on the site of the 
cancer. More than 95 % of colorectal cancer is comprised of adenocarcinoma (Cancer 
Research UK, 2013). Colorectal adenocarcinoma is the cancer that occurs at the gland cells 
that line the walls of the bowel.  
 
The causes and progression of colorectal cancer can be attributed to a wide range of risk 
factors. Studies show that dietary patterns such as excessive alcohol, red and processed 
meat consumption increased colorectal cancer risk whereas the risk decreases with a high 
consumption of fibre as well as fruits and vegetables (Vargas and Thompson, 2012). 
Physical activity was also found to decrease the risk for colorectal cancer (Wolin et al., 
2009).  
 
Bioactive compounds are essential (e.g. proteins) and non-essential (e.g. polyphenols) 
components derived from food constituents that have an effect on human health (Biesalski 
et al., 2009). Studies have shown that bioactive compounds are able to exert anti-
proliferative effects in different types of cancer cells via autophagy, apoptosis, cell cycle 
arrest and interference of cellular signal transduction (Xia et al., 2011; Gan et al., 2015; 
Milutinović et al., 2015).  
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Bioactive peptides derived from various marine sources such as oyster (Umayaparvathi et 
al., 2014), tuna (Hung et al., 2014) as well as Japanese threadfin bream and two-wing 
flying fish (Naqash and Nazeer, 2010) were also found to have anti-proliferative activities 
in cancer cells. Although marine sourced bioactive peptides exhibited anti-proliferative 
effects on cancer cells, the exact mechanisms of the peptides on cancer cells were not 
reported.  
 
Thus, this study uses GF28, a bioactive peptide derived from salmon skin gelatin and 
further purified using ultrafiltration as well as gel filtration. GF28 was used to treat Caco-2 
cells and morphological changes were also observed using a phase contrast microscope. 
The anti-proliferative effects of GF28-treated Caco-2 cells were further elucidated in 
cellular and mitochondria reactive oxygen species (ROS) production as well as other cell 
death mechanisms. 
  
 110 
 
5.2 Methods 
 
5.2.1 Materials and reagents 
 
The following materials and reagents were purchased from the different suppliers: 
 
 
Materials 
 
Supplier 
 
Caco-2 cell line 
 
 
 
 
Sigma-Aldrich (Dorset, UK) 
 
RNase 
 
Propidium iodide (PI) 
 
RIPA buffer 
 
Phenylmethanesulfonylflouride (PMSF) 
 
Dimethyl sulfoxide (DMSO), HPLC grade 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life Technologies (Paisley, UK) 
 
NuPage LDS Sample Buffer 
 
NuPage Sample Reducing Agent 
 
NuPage 10 % Bis-Tris Protein Gels, 15 
wells 
 
Novex Sharp Pre-stained Protein Standard 
 
NuPage MOPS SDS Running buffer 
 
NuPage Transfer Buffer 
 
Invitrolon PVDF/ Filter Paper Sandwich 
WesternBreeze Blocker/Diluent (Part A and 
B) 
 
WesternBreeze Wash solution 
Hank’s Balanced Salt Solution (HBSS) 
(Gibco) 
 
CM-H2DCFDA (Molecular Probes) 
 
MitoSOX (Molecular Probes) 
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Materials 
 
Suppliers 
 
Absolute ethanol, HPLC grade 
 
Fisher Scientific (Leicester, UK) 
 
Methanol, HPLC grade 
 
Annexin V kit  
 
Abcam (Cambridge, UK) 
 
Caspase-Glo 3/7 Assay 
 
Caspase-Glo 8 Assay 
 
 
Promega (Southampton, UK)  
Caspase-Glo 9 Assay 
 
Li-Cor IRDye 800CW AntiMouse 
 
Li-Cor IRDye 800CW AntiRabbit 
 
Li-Cor (Nebraska, USA) 
 
Lamin A/C Mouse mAB  
 
PARP Rabbit mAB 
 
New England Biolabs (Herts, UK) 
 
β-Actin Mouse mAB 
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5.2.2 Extraction and isolation of GF28 
 
Gelatin was extracted from salmon skin using the method described in 2.2.2. GF28 was 
then further isolated from the alcalase hydrolysate according to methods in 2.2.4.  
 
5.2.3 Cell culture 
 
Caco-2 cells (P 32) were grown in similar conditions as described in 4.2.3. P32 to P55 was 
used in all experiments below. 
 
5.2.4 Effect of GF28 on the cell viability of Caco-2 cells (MTT assay) 
 
The MTT assay to observe the effect of GF28 (0.05 – 1.00 mg/mL) on Caco-2 cells was 
performed according to 4.2.4.  
 
5.2.5 Effect of GF28 on Caco-2 cell morphology 
 
Cell morphology of 0.10 and 0.15 mg/mL GF28-treated Caco-2 cells were observed under 
a phase contrast microscope according to 4.2.5.  
 
5.2.6 Effect of GF28 on intracellular reactive oxygen species (ROS) production in 
Caco-2 cells 
 
The chloromethyl derivative of 2’, 7’-dichlorodihydrofluorescein diacetate (CM-
H2DCFDA) dye was used in the assessment of intracellular ROS levels using flow 
cytometry. CM-H2DCFDA is a cell membrane permeable probe. Once inside the cell, the 
probe will undergo cleavage at the acetate group by intracellular esterases. Further 
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oxidation of the probe by ROS converts the probe into a highly fluorescent compound 2’, 
7’-dichloroflourescein (DCF).  
 
Caco-2 cells were seeded at 1 x 10
6
 cells/ 5 mL in 25 cm
2
 flasks. At 50 % confluency, cells 
were treated with 0.10 and 0.15 mg/mL GF28 or media alone, respectively, for 24 h. The 
media was poured into 15 mL centrifuge tubes and washed with 2 mL PBS. Cells were 
harvested using 2 mL trypsin. The trypsinised cells were resuspended using their media 
collected previously and centrifuged at 500 x g for 3 min. The media was then aspirated 
leaving the cell pellet at the bottom of the centrifuge tube. PBS (0.5 mL) and 5 µM CM-
H2DCFDA (5 µL) prepared in DMSO was added to the cell pellet and incubated for 30 
min at 37 °C in 5 % CO2. After the incubation period, cells were kept in the dark and on 
ice. The cellular ROS levels of 10,000 events for each samples were measured using a 
BDFACS Canto flow cytometer (BD Biosciences, USA) using an excitation and emission 
wavelength of 495 and 520 nm respectively.  
 
5.2.7 Mitochondrial reactive oxygen species (ROS) production of GF28-treated cells 
 
The amount of mitochondrial ROS in Caco-2 cells was determined using MitoSOX. 
Similar to CM-H2DCFDA, MitoSOX is also cell-permeable and specifically targets the 
mitochondria. Once in the mitochondria, MitoSOX is oxidised by superoxide and turns to 
a red fluorescent probe which the fluorescent intensity can be detected using flow 
cytometry.  
 
The method for this assay was similar to CM-H2DCFDA (5.2.6) where 5 µM MitoSOX (5 
µL) was added with 0.5 mL cold (Hank’s balanced salt solution) HBSS instead of PBS and 
incubated for 10 min in a 37 °C, 5 % CO2 humidified incubator. After the incubation 
period, cells were kept in the dark and on ice. The mitochondrial ROS levels for 10,000 
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events in each sample were measured using a BD FACS Canto flow cytometer 
(BDBiosciences, USA) with an excitation and emission wavelength of 510 and 580 nm 
respectively. 
 
5.2.8 Cell cycle assessment of GF28-treated cells 
 
The effect of GF28 on the cell cycle of Caco-2 cells was investigated using flow cytometry. 
1 x 10
6
 cells/ 5 mL were seeded in 25cm
2
 flasks for 24 h until 50 % confluent. Then, 0.10 
and 0.15 mg/mL GF28 as well as media alone were used to treat the cells respectively for a 
further 24 h. Media was collected in 15 mL centrifuge tubes and poured back to the 
corresponding flasks after the flasks were washed with 2 mL PBS and trypsinised with 
0.01% trypsin (2 mL). The detached cells in the media were collected in centrifuge tubes 
and pelleted at 500 x g for 3 min in a centrifuge (Labofuge 400R, Heraeus Instruments). 
Media was aspirated and 200 µL of cold PBS and 1 mL of 70 % cold ethanol in PBS were 
added to the cells followed by vortexing. Cells were fixed for 12 h at 4 °C. Then, the tubes 
were centrifuged at 500 x g for 3 min and the fixing solution was discarded. PBS (1 mL) 
was added to wash the cells and 10 µL of RNase was added. The solution was incubated 
for 30 min at 37 °C and 10 µL of propidium iodide (PI) was added to stain the cells. Cells 
were kept on ice and in the dark until analysis using a BD FACS Canto flow cytometer 
(BDBiosciences, USA). 10,000 events were recorded for each sample at 530 nm and 620 
nm as excitation and emission wavelengths respectively.  
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5.2.9 Annexin V and propidium iodide (PI) staining of GF28-treated Caco-2 cells 
 
Anti-proliferative effect pathway of GF28 was investigated by probing treated cells with 
Annexin V (dyes apoptotic cells) and PI (dyes necrotic cells). Cells were seeded at 1 x 10
6
/ 
5 mL in 25cm
2
 flasks for 24 h. Once 50 % confluent, the cells were treated with 0.10 and 
0.15 mg/mL GF28 or control and incubated a further 24 h. Media was collected in 15 mL 
centrifuge tubes and added back to the respective flasks after the flasks were washed with 
2 mL PBS and trypsinised with 2 mL 0.01 % trypsin. Cells were pelleted using 
centrifugation at 500 x g for 3 min and the media was aspirated. Assay buffer (0.5 mL), 
Annexin V (5 µL) and PI (5 µL) were added in sequence and kept in ice until further 
analysis. A sample treated with just media was used for gating. Events (10,000) were 
recorded for each sample where 520 nm was used to detect Annexin V labelling and 625 
nm was used to detect PI labelling in samples.  
 
5.2.10 Caspase 3/7, 8 and 9 assays  
 
The caspase 3/7, 8 and 9 assays were done according to the manufacturer’s instructions. 
Briefly, cells were seeded at 1 x 10
4
 cells/ 100 µL in white 96 well plates. After reaching 
50 % confluency, cells were treated with GF28 (0.10 and 0.15 mg/mL) or media alone as 
control for 24 h. To prepare the reaction reagent, 10 mL of buffer provided was added to 
the substrate. Then, 100 µL of the reaction reagent was added to each well and incubated 
at room temperature for 30 min. The luminescence of each well was read at an excitation 
and emission wavelength of 490 nm and 510-570 nm respectively. For caspase 8 and 9 
assays, an additional 30 µL of MG132 inhibitor was added to the reaction reagent. 
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5.2.11 Western blotting  
 
5.2.11.1 Cell treatment and sample collection 
 
1 x 10
6
 cells/ 5 mL were seeded in T25 flasks. Once 50 % confluent, cells were treated 
with GF28 (0.10 and 0.15 mg/mL) or media alone as control for 24 h. Cells adhered to the 
flasks were scrapped using rubber-policemen and poured into 15 mL centrifuge tubes. The 
tubes were centrifuged at 500 x g for 3 min at 4 °C and the media was aspirated. Cold PBS 
was added to wash the cells and the cells were again centrifuged and PBS aspirated. Lysis 
solution with 1mM phenylmethanesulfonylfluoride (PMSF) (300 µL) was added to each 
tube. Cells were immediately sonicated and put on ice for 30 min. The tubes were 
centrifuged at 500 x g for 3 min and the supernatant was aliquoted and stored at - 80°C 
until further use.   
 
5.2.11.2 Sample preparation, loading and electrophoresis 
 
Samples (15 µg) were added to 2 µL of reducing agent and 4 µL sample buffer. The total 
volume of samples were made up to 15 µL using milliQ water. Samples were heated at 
70 °C for 10 min and chilled on ice prior to use.  
 
A gel was removed from its plastic packaging and the white strip and comb was also 
removed. Running buffer was prepared by adding 50 mL running buffer to 950 mL milliQ 
water. The running buffer was used to rinse the wells of the gel to remove any air bubbles. 
The gel was placed and secured in a chamber. Running buffer was then poured into the 
chamber covering the wells. Samples (15 µL) and protein ladder was added to each well 
respectively. Electrophoresis was run at 120 V for 2 h.  
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5.2.11.3 Gel transfer to membrane 
 
Before the transfer, transfer buffer was prepared by adding 50 mL transfer buffer to 100 
mL methanol and 850 mL milliQ water. Sponge pads, filter papers as well as the transfer 
membrane were soaked in the transfer buffer for at least 5 min. Then, the gel was removed 
from the chamber. The plastic casing was cracked open and the gel was rinsed with the 
transfer buffer thoroughly. A transfer sandwich was assembled using the sequence as 
follow: sponge pad, sponge pad, sponge pad, filter paper, transfer membrane, gel, filter 
paper, sponge pad, sponge pad. The transfer sandwich was placed into a transfer cartridge 
with the gel side of the sandwich facing the cathode (-) electrode. Transfer buffer was then 
used to fill the chamber and run at 30 V for 2.5 h.  
 
5.2.11.4 Blocking 
 
The transfer membrane was removed from the chamber and washed with milliQ water for 
5 min, three times. The membrane was then rolled into a 50 mL centrifuge tube with the 
blocking solution (2 mL diluent A + 3 mL diluents B + 5 % skimmed milk powder) and 
placed in a roller for 1 h at room temperature.  
 
5.2.11.5 Primary antibody probing 
 
The membrane was again removed from the centrifuge tube and rinsed with milliQ water 
for 5 min, three times. The membrane was incubated with the primary antibody solution (2 
mL diluent A + 1 mL diluents B + 7 mL milliQ water + 5 % skimmed milk powder + 1: 
1000 primary antibody) at 4 °C overnight. Mouse monoclonal antibodies were used for 
poly ADP ribose polymerase (PARP) and β-actin probing whereas rabbit monoclonal 
antibody was used for LaminA/C probing.  
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5.2.11.6 Washing and secondary antibody probing 
 
The membrane was washed with 20 mL of wash solution (10 mL antibody wash solution + 
150 mL milliQ water) for 5 min. Washing of membrane was repeated three times. Then, 
the membrane was incubated with the secondary antibody solution (2 mL diluent A + 1 ml 
diluents B + 7 mL milliQ water + 1: 15,000 secondary antibody solution) for 30 min at 
room temperature. The appropriate anti-mouse and anti-rabbit secondary antibodies were 
used according to the type of antibodies in the primary antibody probing. During the 
incubation period, the membrane was kept in the dark to prevent light exposure.  
 
5.2.11.7 Membrane imaging and band density analysis 
 
All membranes were scanned using the Odyssey CLx (LI-COR, USA) with the imaging 
software (Image Studio ver 3.1). A scan resolution of 169 µm was used. Band density 
analysis was performed using Image Studio.  
 
5.2.12 Statistical analysis 
 
All experiments were done in triplicate (unless stated otherwise) and on three different 
occasions. Results were analysed using GraphPad Prism version 6.0. One way analysis of 
variance (ANOVA) was used to compare the means of the data followed by the Tukey’s 
post-hoc test unless stated otherwise. The details of the statistical tests were provided in 
the figure legends. A statistical difference was observed when p ≤ 0.05. Data were 
presented as mean ± standard error of mean (SEM). 
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5.3 Results 
 
5.3.1 Cell viability of Caco-2 cells treated with GF28 
 
The effect of GF28 was investigated in human colorectal adenocarcinoma cells, Caco-2 
cells. In Figure 5.1, 0.05-1.00 mg/mL GF28 was used to treat the Caco-2 cells for 24 h. 
GF28 showed anti-proliferative effects in Caco-2 cells where cell viability was shown to 
decrease with increasing concentrations of GF28. The number of viable cells was 
significantly lower than the untreated cells when treated with 0.15-1.00 mg/mL GF28. 
Cells treated with lower than 0.15 mg/mL GF28 had no significant differences in cell 
viability compared to the control. The number of viable cells treated with 0.15 mg/mL was 
64.9 %. Cell viability was 32.0 % in 1.0 mg/mL GF28-treated cells.   
 
To further elucidate the anti-proliferative effect of GF28 on Caco-2 cells, GF28 
concentrations used were 0.10 and 0.15 mg/mL respectively. 
 
 
 
Figure 5.1 Cell viability of Caco-2 cells treated with GF28 for 24 h. Caco-2 cells were cultured and 
incubated with GF28 over a concentration range of 0.05-1.00 mg/mL respectively. Means were compared 
using ANOVA followed by the Tukey’s post hoc test. A significant difference (p ≤ 0.05) to the cell viability 
of untreated cells was represented by a.  Data correspond to the mean ± SEM (n = 18). 
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5.3.2 Morphological changes of Caco-2 cells treated with GF28 
 
After a 24 h incubation period, untreated and treated (0.10 and 0.15 mg/mL GF28) Caco-2 
cells were observed under a phase contrast microscope at 10 x magnification (Figure 5.2). 
Treated cells (0.10 mg/mL GF28) showed slight differences in the morphology to the 
untreated cells, whereas 0.15 mg/mL GF28-treated cells were visibly different from the 
untreated cells. In Figure 5.2C, the cell membrane and cellular contents were not clearly 
visible in cells treated with 0.15 mg/mL GF28.  Apart from that, a higher amount of dead 
cells were observed in 0.15 mg/mL treated cells compared to the untreated cells. 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5.2 Morphology of Caco-2 cell line in (A) untreated cells, (B) cells treated with 0.10 mg/mL GF28, 
and (C) cells treated with 0.15 mg/mL GF28. Caco-2 cells were incubated with the treatments above for 24 h 
and observed under light microscope. Images captured were at 10 x magnification. 
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5.3.3 Intracellular and mitochondrial reactive oxygen species (ROS) by GF28-treated 
Caco-2 cells 
 
Figure 5.3 showed the ROS levels produced when Caco-2 cells were treated with 0.10 and 
0.15 mg/mL GF28 respectively compared to the control. Intracellular and mitochondrial 
ROS production (Figure 5.3A and Figure 5.3B respectively) in GF28-treated Caco-2 cells 
was lower compared to the control. Intracellular and mitochondrial ROS production 
decreased when concentrations of GF28 used increased.  In Figure 5.3A, intracellular 
ROS production was 23.6 % (0.10 mg/mL) and 15.3 % (0.15 mg/mL) compared to 32.9 % 
for the control. Mitochondrial ROS production in the control was 25.2 % compared to 
14.3 % and 7.8 % in 0.10 and 0.15 mg/mL GF28-treated cells (Figure 5.3B). In both 
intracellular and mitochondrial ROS production, 0.15 mg/mL GF28-treated Caco-2 cells 
were significantly lower than the control.    
 
 
 
 
 
 
Figure 5.3 (A) Intracellular ROS and (B) mitochondrial ROS production of Caco-2 cells treated with GF28 
for 24 h. Caco-2 cells were cultured and incubated with GF28 of 0.10 and 0.15 mg/mL respectively. Caco-2 
cells incubated with media alone were used as control. Means were compared using ANOVA followed by the 
Tukey’s post hoc test. A significant difference (p ≤ 0.05) to the ROS production of the control was 
represented by a.  Data correspond to the mean ± SEM (n = 9). 
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5.3.4 Cell cycle assessment of GF28-treated Caco-2 cells 
 
As GF28 showed anti-proliferative effects on Caco-2 cells, the cell cycle arrest of GF28-
treated cells was investigated (Figure 5.4). In this assay, cells were treated with 0.10 and 
0.15 mg/mL GF28 respectively for 24 h. Propidium iodide (PI) was then used to stain 
DNA where the intensity of the PI signal is proportional to the amount of DNA present.  
 
Prior to mitosis, the different phases of the cell cycle are as follows: G1 phase (Growth 
phase 1), S phase (DNA synthesis phase) and G2 phase (Growth phase 2). The cell 
population in the different cell cycle phases of the control were 69.9 % (G1), 10.5 % (S) 
and 19.5 % (G2). Cells treated with 0.10 mg/mL GF28 exhibited similar cell cycle patterns 
to the control (69.1 %, 9.2 % and 21.8 % for G1, S and G2 phases respectively). However, 
when Caco-2 cells were treated with 0.15 mg/mL GF28, G1 phase significantly increased 
(79.4 % vs 69.9 %) and G2 phase significantly decreased (12.8 % vs 19.5 %) compared to 
the control. 
 
  Figure 5.4 Effect of GF28 on cell cycle in Caco-2 cells using flow cytometry. Caco-2 cells were cultured and 
incubated with GF28 of 0.10 and 0.15 mg/mL respectively for 24 h. Caco-2 cells incubated with media alone 
were used as control. Then, cells were fixed using 70 % ethanol and stained with PI. 10,000 cells were 
counted for each sample. Phases of cell cycle of Caco-2 cells were classified into G1 (Growth phase 1), S 
(DNA synthesis phase) and G2 (Growth phase 2). Means of the different phases between the different 
samples were compared using ANOVA followed by the Tukey’s post hoc test. A significant difference (p ≤ 
0.05) to the control was represented by a.  Data correspond to the mean ± SEM (n = 9). 
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5.3.5 Annexin V and propidium iodide (PI) staining of GF28-treated Caco-2 cells 
 
The effect of GF28 on phosphatidylserine (PS) externalisation in Caco-2 cells were also 
investigated (Figure 5.5). Essentially, Annexin V conjugates and stains PS which indicates 
cell death via apoptosis whereas PI stains DNA which indicates cell death via necrosis.  
 
Flow cytometry charts of the control as well as treated Caco-2 cells (0.10 and 0.15 mg/mL 
GF28 respectively) are shown in Figure 5.5A. Each graph consist of four quadrants which 
represent: healthy (H), apoptotic (A), necrotic (N) as well as necrotic and/or late apoptotic 
(NA) cells. Compared to the control, it can be observed from the flow cytometry charts 
that when the concentration of GF28 increased there was a gradual increase in the cell 
population in A and NA quadrants as well as a decrease in the H quadrant.   
 
The charts were then further represented using bar graphs in Figure 5.5B. The cell 
population of the untreated cells (control) in the different quadrants are 90.7 % (H), 0.8 % 
(N), 1.1 % (A) and 7.4 % (NA). In general, apart from the cell population in the N 
quadrant the cell population in H, A and NA quadrants in GF28-treated cells were 
significantly different to the control. The number of healthy cells significantly decreased 
when cells were treated with 0.10 and 0.15 mg/mL GF28 (70.8 % and 43.3 % respectively) 
when compared to 90.7 % control. Apart from that, the cell population of 0.10 and 0.15 
mg/mL GF28-treated Caco-2 cells in A (6.5 % and 29.2 % respectively) and NA (21.5 % 
and 24.0 % respectively) was significantly higher than the control.  
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Figure 5.5 Effect of GF28 on cell death pathway of Caco-2 cells using flow cytometry. Caco-2 cells were 
cultured and incubated with GF28 of 0.10 and 0.15 mg/mL respectively for 24 h. Caco-2 cells incubated with 
media alone were used as control. (A) Flow cytometry charts of cells treated with (i) control (ii) 0.10 mg/mL 
GF28 and (iii) 0.15 mg/mL GF28. Cells were then stained with Annexin-V and PI. Then, 10,000 cells were 
counted for each sample where the cell population was categorised into four quadrants: Healthy (H), 
Apoptotic (A), Necrotic (N) as well as Necrotic and/or apoptotic (NA). (B) Graphical representation of the 
flow cytometry charts. Means of the different quadrants between the different samples were compared using 
ANOVA followed by the Tukey’s post hoc test. A significant difference (p ≤ 0.05) to the control was 
represented by a.  Data correspond to the mean ± SEM (n = 9). 
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5.3.6 Intrinsic pathway of apoptosis  
 
5.3.6.1 Expression of caspase-9 
 
As staining of Caco-2 cells treated with GF28 showed cell death via the apoptosis. The 
different pathways of apoptosis were investigated. Caspase-9 is involved in the intrinsic 
signalling pathway of apoptosis. Figure 5.6 illustrated the effect of GF28 on the caspase-9 
expression of Caco-2 cells. The luminescence unit of the control was set at 50 RLU. 
Caspase 9 expression of 0.10 mg/mL GF28-treated cells (59.3 RLU) was not significantly 
different to the control. However, the caspase-9 expression was shown to significantly 
increase in 0.15 mg/mL GF28-treated cells (116.3 RLU) compared to the control.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 Effect of GF28 on caspase-9 expression using luminescence assay. Caco-2 cells were cultured and 
incubated with GF28 of 0.10 and 0.15 mg/mL respectively for 24 h. Caco-2 cells incubated with media alone 
were used as control. Excitation wavelength used was 490 nm and the emission wavelength was 510 nm. The 
luminescence of each sample was expressed as the relative luminescence units (RLU) normalised to the 
control (50 RLU). Mean RLU of the different samples were compared using ANOVA followed by the 
Tukey’s post hoc test. A significant difference (p ≤ 0.05) to the control was represented by a.  Data 
correspond to the mean ± SEM (n = 9). 
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5.3.6.2 Effect of GF28 on the activation of Lamin A and Lamin C in Caco-2 cells 
 
As GF28 showed anti-proliferative effects on Caco-2 cells via caspase-9 activation, the 
effects of GF28 on cleaved Lamin A and C were further investigated in Figure 5.7. The 
expression of cleaved Lamin A and C in Caco-2 cells treated with GF28 were compared to 
untreated cells (control) using western blot analysis. Figure 5.7A showed the western blot 
membrane of the expression of cleaved Lamin A and C using β-actin as the loading control. 
The activation of Lamin A and C can be observed from the amount of Lamin A and C 
cleaved. Darker bands for cleaved Lamin A (41 kDa) and cleaved Lamin C (28 kDa) were 
observed in 0.15 mg/mL GF28-treated Caco-2 cells compared to the control.  
 
In Figure 5.7B, the activation of both Lamin A and Lamin C was standardised to 1. Lamin 
A activation of 0.10 and 0.15 mg/mL GF28-treated Caco-2 cells were 2.9 and 9.7 fold 
respectively when compared to the control. In addition, Lamin C activation for GF28-
treated cells were 2.5 and 9.6 fold (0.10 and 0.15 mg/mL GF28 respectively) to the 
expression of control. In conclusion, compared to the control, the Lamin A and C 
activation significantly increased in 0.15 mg/mL GF28-treated Caco-2 cells whereas the 
0.10 mg/mL GF28-treated cells showed no difference in its Lamin A and C activation.  
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Figure 5.7 Effect of GF28 on Lamin A and C activation using western blot. Caco-2 cells were cultured and 
incubated with GF28 of 0.10 and 0.15 mg/mL respectively for 24 h. Caco-2 cells incubated with media alone 
were used as control. Cell lysate was then collected using RIPA buffer with a protease inhibitor cocktail and 
PMSF. (A) Western blot membrane showing Lamin A (74 kDa), Lamin C (63 kDa), cleaved Lamin A (41 
kDa) and cleaved Lamin C (28 kDa) for each sample. β-actin (45 kDa) was used as a loading control. (B) 
Graphical representation of (i) Lamin A and (ii) Lamin C activation by the band density of cleaved Lamin A 
and cleaved Lamin C respectively. The band density of each sample was expressed as activation of Lamin A 
or C of sample normalised to the control which was set at 1. Expression of the different samples was 
compared using ANOVA followed by the Tukey’s post hoc test. A significant difference (p ≤ 0.05) to the 
control was represented by a.  Data correspond to the mean ± SEM (n = 9). 
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5.3.7 Extrinsic pathway of apoptosis 
 
5.3.7.1 Expression of caspase-8 and caspase-3/7 in GF28-treated cells compared to 
untreated cells 
 
Although apoptosis can be regulated by the intrinsic pathway, apoptosis can also be 
activated via the extrinsic pathway. Caspase-8 and caspase-3/7 are located at the 
downstream signalling of the extrinsic pathway. 
 
Caspase-8 and caspase-3/7 expression are expressed as RLU in Caco-2 cells treated with 
GF28 compared to untreated cells (control) in Figure 5.8. Caspase-8 expression in GF28-
treated cells (78.0 RLU and 112.5 RLU for 0.10 and 0.15 mg/mL respectively) were 
significantly higher compared to the control (50 RLU). For caspase-3/7 expression, the 
RLU of 0.10 and 0.15 mg/mL GF28 (78.6 RLU and 122.6 RLU respectively) treated cells 
were also significantly higher compared to the control (50 RLU). Thus, indicating that the 
anti-proliferative effect of GF28 in Caco-2 was also due to the activation of caspase-8 as 
well as caspase-3/7 which are responsible for the extrinsic pathway of apoptosis.  
 
 
 
  
Figure 5.8 Effect of GF28 on (A) caspase-8 and (B) caspase-3/7 expression using luminescence assay. Caco-
2 cells were cultured and incubated with GF28 of 0.10 and 0.15 mg/mL respectively for 24 h. Caco-2 cells 
incubated with media alone were used as control. Excitation wavelength used was 490 nm and the emission 
wavelength was 510 nm. The luminescence of each sample was expressed as the relative luminescence units 
(RLU) normalised to the control (50 RLU). Mean RLU of the different samples were compared using 
ANOVA followed by the Tukey’s post hoc test. A significant difference (p ≤ 0.05) to the control was 
represented by a.  Data correspond to the mean ± SEM (n = 9). 
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5.3.7.2 Effect of GF28 on PARP activation  
 
The activation of caspase-3/7 in GF28-treated Caco-2 cells indicated that the extrinsic 
pathway as one of its anti-proliferative apoptotic pathway. Effect of GF28 on the 
activation of PARP was further investigated in Figure 5.9. Using β-actin as a loading 
control, the western blot membrane (Figure 5.9A) showed darker bands of cleaved PARP 
(89 kDa) in GF28-treated Caco-2 cells compared to the control. PARP activation is 
indicated by PARP cleavage, thus 0.15 mg/mL showed high PARP activation by its darker 
band in the cleaved PARP.  
 
PARP activation is further represented in a bar graph (Figure 5.9B). PARP activation 
normalised to the control of 0.10 mg/mL and 0.15 mg/mL (3.2 fold and 5.2 fold 
respectively) were significantly higher than the control (normalised to 1).  
 
 
  
 
 
 
  
Figure 5.9 Effect of GF28 on PARP activation using western blot. Caco-2 cells were cultured and incubated 
with GF28 of 0.10 and 0.15 mg/mL respectively for 24 h. Caco-2 cells incubated with media alone were used 
as control. Cell lysate was then collected using RIPA buffer with a protease inhibitor cocktail and PMSF. (A) 
Western blot membrane PARP (116 kDa) and cleaved PARP (89 kDa) for each sample. β-actin (45 kDa) was 
used as a loading control. (B) Graphical representation of PARP activation by the band density of cleaved 
PARP. The band density of each sample was expressed as activation of sample normalised to the control 
which was set at 1. Activation of PARP in different samples was compared using ANOVA followed by the 
Tukey’s post hoc test. A significant difference (p ≤ 0.05) to the control was represented by a.  Data 
correspond to the mean ± SEM (n = 9). 
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5.4 Discussion 
 
The cell viability results (Figure 5.1) and morphological observations (Figure 5.2) 
indicated that GF28 had anti-proliferative effects on human colorectal adenocarcinoma 
cells. Caco-2 cells treated with GF28 concentration of 0.15 mg/mL were able to show 
significant cell death after 24 h compared to the untreated cells as control. IC50 of GF28 
was also shown to be 0.16 mg/mL from the MTT results. Under the phase contrast 
microscope, 0.10 mg/mL GF28-treated cells had similar morphology whereas 0.15 mg/mL 
GF28-treated Caco-2 cells exhibited significant morphological changes compared to the 
control. Therefore, the GF28 concentration used in this study to further elucidate the cell 
death mechanism in Caco-2 cells was 0.10 and 0.15 mg/mL.  
 
Apart from causing damage to proteins, lipids and DNA, excess ROS can also act as 
mediators towards cell death (Marchi et al., 2012). Mounting evidence of mitochondrial 
ROS in particular, can lead to the release of pro-apoptotic proteins which can trigger 
programmed cell death (Thornton and Hagberg, 2015; Fleury et al., 2002). Thus, GF28 
can cause mitochondrial dysfunction which lead to excess ROS production and cell death.  
 
Although GF28 showed anti-proliferative effects according to the MTT and morphological 
observations, intracellular and mitochondrial ROS decreased in GF28-treated cells 
compared to control (Figure 5.3). The observed results may be due to GF28 acting as an 
efficient antioxidant as described in Chapter 3.  
 
GF28-treated Caco-2 cells also showed cell cycle arrest at the G1 phase (Growth phase 1). 
The accumulation of cell population in the G1 phase suggested that cells are blocked in the 
transition of G1 to S phase. During the G1 phase, DNA replication and the transition to S 
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phase is initiated via the activity of growth dependant cyclin dependant kinase (CDK) 
(Bertoli et al., 2013). This suggests that GF28 may be able to alter CDK activity which 
could prevent Caco-2 cells progressing to the S phase, leading to the prevention of Caco-2 
cell growth and proliferation.  
 
As cell death mechanisms can be divided into apoptosis, necrosis and necroptosis, the anti-
proliferative mechanism of GF28 in Caco-2 cells was further investigated. Annexin V and 
PI were used to identify the cell death pathway of the Caco-2 cells treated with GF28 for 
24 h. Annexin V conjugates and stains apoptotic cells whereas PI stains necrotic cells. It 
was shown that increasing GF28 concentration increased the number of apoptotic as well 
as late apoptotic and/or necrotic cells. The cell population classified as apoptotic cells were 
6.5 % and 29.2 % (0.10 and 0.15 mg/mL respectively) compared to 1.1 % in the control. 
Thus, GF28 was shown to cause cell death in Caco-2 cells via apoptosis.  
 
The different apoptosis pathway of Caco-2 cells treated with GF28 was further 
investigated in this study. There are two general apoptosis signalling pathway: the intrinsic 
pathway is activated by cellular stress and involves the mitochondria signalling cascade 
and caspase-9 downstream; the extrinsic pathway involves the activation of death receptor 
ligands and caspase-8 downstream (Fulda and Debatin, 2006). Both intrinsic and extrinsic 
pathways will cleave caspase-3/7 which would further induce apoptosis (Chipuk and 
Green, 2006). 
 
GF28 showed induction of apoptosis via the intrinsic pathway by caspase-9 activation. 
Caco-2 cells treated with 0.15 mg/mL GF28 showed 116.3 RLU compared to 50.0 RLU in 
the control. The downstream activation of the intrinsic pathway was also further confirmed 
via the activation of Lamin A and C. Both Lamin A and C are cleaved by caspase-6 which 
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is the downstream of caspase-9. GF28-treated cells showed significantly higher Lamin A 
and C cleavage compared to the control. Cleavage of Lamin A and C shown in Figure 5.7 
also indicated the activation of both Lamin A and C. This is responsible for the shrinkage 
of cell and membrane blebbing during apoptosis.  
 
Activation of caspase-8 is also one of the key signalling mediators in the extrinsic pathway 
of apoptosis. As illustrated in Figure 5.8, GF28 was also able to induce higher expression 
of caspase-8 in Caco-2 cells. Apart from that, GF28 also showed activation of caspase-3/7 
which is downstream of both the extrinsic and intrinsic pathway.  
 
The activation of caspase-3/7 was confirmed via western blotting of PARP (Figure 5.9). In 
the attempt of cellular repair, activation of PARP causes ATP depletion. However, excess 
ATP depletion can also trigger cell lysis and cell death via necrosis (Los et al., 2002; Fan 
and Jong, 2014). Apart from that, upon activation of PARP, poly(ADP-ribose) (PAR) will 
translocate from the cytosol to the outer membrane of mitochondria (Yu et al., 2006). This 
would lead to the release of apoptosis inducing factor (AIF) which can cause pro-apoptotic 
activities of DNA fragmentation and chromatin condensation (McGill et al., 2012; Doti et 
al., 2014).  
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5.5 Conclusion 
 
GF28, a peptide derived from salmon skin gelatin, exhibited anti-proliferative effects in 
human colorectal adenocarcinoma cells (Caco-2). MTT results exhibited IC50 of 0.16 
mg/mL for GF28. Caco-2 cells treated with 0.15 mg/mL GF28 also showed significant 
morphological changes when compared to the control. Intracellular and mitochondrial 
ROS was also significantly lower in GF28-treated cells.   
 
Cell cycle studies in Caco-2 cells also showed that cells treated with GF28 induced cell 
cycle arrest at the G1 phase, preventing the cells to continue to the S phase for DNA 
replication. Apart from that, it was shown that GF28-treated cells undergo apoptosis 
instead of necrosis as the cell death mechanism.  
 
Apoptosis can be divided into the intrinsic and extrinsic pathway. GF28 was also able to 
induce caspase-9 cleavage and activation of Lamin A and C which are involved in the 
extrinsic apoptosis pathway. Besides that, Caco-2 treated with GF28 also showed 
significantly higher activation of caspase-8 which is a key mediator in the intrinsic 
apoptotic pathway. Results also showed the activation of caspase-3/7 and PARP which are 
the downstream of both the extrinsic and intrinsic pathway.  
 
In conclusion, GF28 showed anti-proliferative effects on Caco-2 cells; the cells underwent 
programmed cell death, apoptosis. The apoptosis pathway induced by GF28 was also 
elucidated in this study. GF28 showed promising results in terms of the anti-proliferative 
mechanism which involved apoptosis in colorectal carcinoma cells. However, more studies 
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are still needed to further investigate the exact anti-proliferative pathways induced by 
GF28. 
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Chapter 6 
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6 General discussion and conclusion 
 
6.1 General discussion 
 
6.1.1 Isolation and purification of peptides from salmon skin gelatin 
 
The increasing demand for products derived from natural sources over the past decade can 
be attributed to the increased awareness in the potential health benefits of these products. 
Bioactive peptides in particular, are given much attention as they can be easily derived 
from natural sources and many studies showed that bioactive peptides exhibited a wide 
range of health benefits.   
 
In this study, gelatin was extracted from salmon skin using an acidic extraction method. 
Pepsin, alcalase and collagenase were used to hydrolyse the extracted gelatin. The most 
potent hydrolysate was further purified by ultrafiltration and gel filtration. To obtain a 
peptide fraction with the highest activity, the antioxidant and ACE inhibition activity 
amongst the hydrolysates as well as the ultrafiltered and gel filtered purified fractions were 
compared. 
 
Antioxidant and ACE inhibition activity (61.6 % and 59.0 %, respectively) of the alcalase 
hydrolysate were higher compared to the pepsin and collagenase hydrolysates. As 
mentioned above, the alcalase hydrolysate was further purified. The antioxidant activity 
did not significantly differ amongst the purified fractions whereas GF28 showed the 
highest ACE inhibition activity. Thus, GF28 from the gel filtration fraction was chosen for 
further investigation in this study.  
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6.1.2 ACE inhibition mechanisms of GF28 
 
The ACE inhibition mechanisms of GF28 were investigated with enzyme kinetics. A 
Lineweaver Burk plot illustrated similar Vmax values (10.5 mM/min) but different Km 
values; this indicated that GF28 acts as a competitive inhibitor on ACE.  
 
A zinc ion can be found in the active site of ACE and the chelation of the metal ion can 
lead to ACE inhibition effects. Thermodynamics results showed GF28 was able to bind to 
zinc ions. This result further confirmed the enzyme kinetic findings which showed 
competitive inhibition of ACE by GF28. 
 
6.1.3 Antioxidant mechanisms of GF28 
 
The reducing power, radical scavenging ability and metal ion chelation ability of GF28 
were investigated to determine its antioxidant mechanism. There was only a slight increase 
in the reducing power activity with increasing concentration of GF28. The maximum 
reducing power activity exhibited by 10 mg/mL GF28 was 9.8 %. DPPH and ABTS 
radical scavenging assays measure the ability of GF28 to act as an electron donor in both 
hydrophobic and hydrophilic environment. GF28 showed poor DPPH and ABTS 
scavenging activity (3.5 % and 4.5 % respectively). However, the transition metal ions 
chelation activity of GF28 was high. GF28 was able to effectively chelate iron and copper 
transition ions (IC50: 1.0 and 7.6 mg/mL respectively).  
 
Thus, the high antioxidant activity observed in GF28 may be mainly attributed to the high 
transition metal ion chelating activity.  
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6.1.4 Amino acid composition of GF28 
 
Amino acid results showed that GF28 was mainly comprised of glycine (42.2%) and 
hydrophobic amino acid (28.3 %) was the predominant amino acid group. The presence of 
hydrophobic as well as bulky aromatic amino acids (9.2 %) play a role in ACE inhibition 
whereby aromatic amino acids can bind to ACE, blocking its active site.  The amount of 
hydrophobic amino acid may also be responsible for the antioxidant activity of GF28. The 
high transition metal ion chelating activity of GF28 may be associated with the 
hydrophobic amino acid.  
 
6.1.5 Effect of GF28 in hepatocellular carcinoma cells 
 
HepG2 cells were used as a model of hepatocellular carcinoma cells to investigate the 
effect of GF28. MTT results showed that GF28 exhibited anti-proliferative effects in 
HepG2 cells; the IC50 of GF28 was determined as 0.154 mg/mL. This was confirmed in 
GF28-treated HepG2 cells observed under the phase contrast microscope. The increase in 
GF28 concentration in HepG2 cells led to an increase in cell death. As liver is the main 
detoxifying organ in the body and GF28 showed anti-proliferation effects on HepG2 cells, 
the effect of GF28 in the endogenous antioxidant system was investigated.  
 
A higher amount of SOD is expressed in cancer cells compared to normal cells. Apart 
from that, the rapid recovery of SOD in injured cancer cells may pose as a survival 
mechanism for cancer cells. Thus SOD may act as a target for hepatocellular carcinoma 
cells. An increase in GF28 concentration led to a significant decrease in SOD activity. The 
SOD activity in 0.175 mg/mL GF28-treated cells was significantly lower than untreated 
cells (46.2 % vs 73.5 %). SOD can be divided into several isoforms according to the 
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different redox active metals at the catalytic site. The significant decrease in SOD activity 
may be due to the high metal ion chelation activity of GF28.  
 
Due to the decrease of SOD in GF28-treated cells, the amount of H2O2 produced will 
decrease. Thus the decrease in catalase activity is expected in GF28-treated cells compared 
to untreated cells as catalase catalyses the conversion of H2O2 to oxygen and water. 
However, GF28-treated HepG2 cells showed an increase in catalase activity. GF28 may 
induce ER stress which can lead to UPR activation, acting as another source of H2O2.  
 
GF28 also affected the endogenous antioxidant system by decreasing the amount of total 
glutathione and GPx activity. In addition, the GR activity was unchanged in GF28-treated 
HepG2 cells. 
 
The above effects of GF28 on the endogenous antioxidant defence system may play a role 
in the development of liver cancer treatment.  
 
6.1.6 Effect of GF28 on colorectal adenocarcinoma cells 
 
Colorectal cancer is the fourth most common cancer in the UK. Caco-2 cells were used in 
this study to illustrate the effect of GF28 on colorectal adenocarcinoma cells. GF28 
showed toxicity effects on Caco-2 cells causing cell death. IC50 was determined to be 0.16 
mg/mL. Morphological changes of GF28-treated Caco-2 cells also confirmed the anti-
proliferative effects of GF28. 
 
In general, injured cells can lead to increased ROS production. However, intracellular and 
mitochondria ROS production in 0.15mg/mL GF28-treated Caco-2 cells were significantly 
lower than untreated cells. The lower ROS produced may be due to the antioxidant activity 
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of GF28. Further cell cycle studies of GF28-treated Caco-2 showed cell cycle arrest at the 
G1 phase. The accumulation of cell population in the G1 phase suggested that cells are 
blocked in the transition of G1 to S phase. 
 
Cell death can be divided into apoptosis, necrosis and necroptosis. As GF28 induced cell 
death in Caco-2 cells, flow cytometry using Annexin V and PI was used to stain dying 
cells to determine the cell death pathway. It was shown that increasing GF28 concentration 
increased the number of apoptotic as well as late apoptotic and/or necrotic cells. 
 
The apoptotic pathway of GF28-treated Caco-2 cells was further investigated. The 
extrinsic as well as intrinsic apoptotic pathways were activated in GF28-treated Caco-2 
cells. GF28 was found to activate the intrinsic apoptotic pathway via the activation of 
caspase-9 as well as the downstream signaling of Lamin A and Lamin C which are 
responsible for cell shrinkage and membrane blebbing. The extrinsic apoptotic pathway 
was also activated by GF28. Caspase-8 and its downstream signaling of caspase-3/7 were 
activated. This was confirmed via western blotting of PARP that is responsible for DNA 
fragmentation and chromatin condensation during apoptosis.  
  
 141 
 
6.2 General conclusions 
 
 Alcalase hydrolysed salmon skin gelatin hydrolysate had higher antioxidant and 
ACE inhibition activity than pepsin and collagenase hydrolysates.  
 The most potent fraction of the alcalase hydrolysate purified by ultrafiltration and 
gel filtration was GF28.  
 Enzyme kinetics showed that GF28 acts as a competitive inhibitor of ACE. This 
was further confirmed by the thermodynamic study which showed that GF28 was 
able to bind zinc. Zinc ions are located in the active site of ACE, which play a role 
in its activity.  
 GF28 showed potent transition metal ion chelating activity and low reducing power 
activity. Radical scavenging activity was also poor in GF28. 
 Amino acid composition of GF28 indicated the high amount of hydrophobic amino 
acids (28.3 %) may play a role in its antioxidant and ACE inhibition activity. 
 GF28 exhibited anti-proliferative effects in both hepatocellular carcinoma (HepG2) 
and colorectal adenocarcinoma (Caco-2) cell lines.  
 The effects of GF28 on the endogenous antioxidant defence system may play a role 
in the cytotoxicity effects on HepG2 cells.  
 GF28 decreased SOD and GPx activities as well as the amount of total glutathione 
whereas it increased catalase activity. However, GF28 did not affect GR in HepG2 
cells.  
 Although GF28 induced cell death in Caco-2 cells, intracellular and mitochondrial 
ROS decreased; this may be due to the antioxidant activity of GF28. 
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 Caco-2 cells treated with GF28 showed cell cycle arrest at the G1 phase. Caco-2 
cells were prevented from progressing to the S phase in which DNA replication 
takes place.  
 Caco-2 cells conjugate with Annexin V and stained with PI showed GF28 induced 
cell death via apoptosis. 
 Intrinsic apoptotic pathway was activated in GF28-treated Caco-2 cells. Caspase-9 
as well as Lamin A and Lamin C, responsible for membrane blebbing and cell 
shrinkage, were significantly higher in GF28-treated Caco-2 cells than untreated 
cells. 
 GF28 also led to apoptosis via the extrinsic pathway. Caspase-8, caspase-3/7 and 
PARP cleavage were observed, indicating apoptotic cell death via death receptor 
ligand activation. 
 
6.3 Future work 
 
In this study, several bioactive properties were elucidated using a bioactive peptide, GF28, 
produced from salmon skin gelatin. This included ACE inhibition activity and antioxidant 
properties, as well as anti-proliferative effects on hepatocellular and colorectal 
adenocarcinoma cell lines. However, more research can be done in each of these areas e.g. 
elucidation of structure-function relationship and absorption of the peptide using a Caco-2 
cell line monolayer model. 
 
The ACE inhibition activity study can be further investigated in animal studies. 
Spontaneously hypertensive rats are commonly used as hypertensive models. In addition, 
the effect of GF28 on other blood pressure regulation system or mediators such as calcium 
ions can also be investigated using cell lines.  
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Compared to most antioxidants used in food products which act as hydrogen donors, GF28 
is an effective metal chelator. For future studies, GF28 may be incorporated into food 
products with other hydrogen donating antioxidants such as ascorbate. This combination of 
antioxidants with different antioxidant mechanisms may show synergistic effects that 
retard lipid oxidation more effectively. 
 
As GF28 also showed promising anti-proliferative results in liver and colorectal cancer, 
more evidence is needed to further develop GF28 as a cancer therapy. Microarray analysis 
is a useful technique to further elucidate the effect of GF28 on gene expression. Other cell 
death pathways such as autophagy and necroptosis can also be investigated. Cell death 
pathways induced by GF28 can also be compared to known anti-cancer drugs. 
 
As elucidated in this study, bioactive peptides have many health benefits. Different 
bioactive peptides can be derived from different sources using different enzymes. This can 
lead to bioactive peptides with different lengths and amino acid sequence, thus different 
bioactive properties as well as mechanisms. There is a huge potential in the field of 
bioactive peptides but more detailed studies have to be undertaken. 
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